Signaling	O
pathways	O
mediated	O
by	O
the	O
TNF-	B-protein
and	I-protein
cytokine-receptor	I-protein
families	O
target	O
a	O
common	O
cis-element	B-DNA
of	O
the	O
IFN	B-DNA
regulatory	I-DNA
factor	I-DNA
1	I-DNA
promoter	I-DNA
.	O

CD40	B-protein
activation	O
of	O
B	B-cell_type
cells	I-cell_type
is	O
strongly	O
influenced	O
by	O
the	O
presence	O
of	O
cytokines	B-protein
.	O

However	O
,	O
the	O
molecular	O
basis	O
for	O
the	O
interplay	O
between	O
these	O
distinct	O
stimuli	O
is	O
not	O
clearly	O
delineated	O
.	O

IFN	B-protein
regulatory	I-protein
factor	I-protein
1	I-protein
(	O
IRF-1	B-protein
)	O
is	O
a	O
transcription	B-protein
factor	I-protein
activated	O
by	O
either	O
CD40	B-protein
or	O
cytokines	B-protein
.	O

We	O
have	O
found	O
that	O
these	O
different	O
sets	O
of	O
signals	O
target	O
a	O
common	O
cis-acting	O
element	O
in	O
the	O
promoter	O
of	O
this	O
gene	O
,	O
the	O
IRF-1	B-DNA
gamma-activated	I-DNA
site	I-DNA
(	O
GAS	B-DNA
)	O
.	O

Targeting	O
of	O
the	O
IRF-1	B-DNA
GAS	I-DNA
is	O
not	O
confined	O
to	O
activation	O
via	O
CD40	B-protein
but	O
extends	O
to	O
other	O
stimuli	O
that	O
mimic	O
the	O
CD40	B-protein
signaling	O
cascade	O
,	O
like	O
TNF-alpha	B-protein
and	O
EBV	O
.	O

In	O
contrast	O
to	O
induction	O
of	O
STATs	B-protein
by	O
cytokines	B-protein
,	O
the	O
IRF-1	B-DNA
GAS	I-DNA
-binding	O
complex	O
activated	O
by	O
CD40	B-protein
,	O
TNF-alpha	B-protein
,	O
or	O
EBV	O
contains	O
Rel	B-protein
proteins	I-protein
,	O
specifically	O
p50	B-protein
and	O
p65	B-protein
.	O

In	O
this	O
system	O
,	O
simultaneous	O
exposure	O
to	O
CD40L	B-protein
together	O
with	O
either	O
IL-4	B-protein
or	O
IFN-gamma	B-protein
does	O
not	O
lead	O
to	O
the	O
activation	O
of	O
novel	O
Rel/STAT	B-protein
complexes	I-protein
.	O

Given	O
the	O
importance	O
of	O
IRF-1	B-protein
in	O
a	O
variety	O
of	O
biologic	O
functions	O
from	O
proliferation	O
to	O
apoptosis	O
,	O
our	O
findings	O
support	O
the	O
notion	O
that	O
modulation	O
of	O
IRF-1	B-protein
levels	O
may	O
be	O
a	O
critical	O
control	O
point	O
in	O
B	O
cell	O
activation	O
.	O

``	NULL
n	NULL
vivo	NULL
,	NULL
RE	NULL
SEARCH	NULL
*	NULL
Discover	NULL
More	NULL
j	NULL
has	NULL
J	NULL
me	NULL
Journal	NULL
o	NULL
Signaling	NULL
Ifathways	NULL
Mediatesi	NULL
.by	NULL
the	NULL
TNF	NULL
415k	NULL
Immunolo	NULL
gy	NULL
and	NULL
Cytokine-Receptor	NULL
Families	NULL
Target	NULL
a	NULL
Common	NULL
cis-Element	NULL
of	NULL
the	NULL
IFN	NULL
Regulatory	NULL
Factor	NULL
1	NULL
Promoter	NULL
BULLANTBODIE	NULL
-	NULL
CTSA	NULL
)	NULL
Cor	NULL
C25	NULL
'Can	NULL
3	NULL
)	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Sanjay	NULL
Gupta	NULL
,	NULL
Dengfeng	NULL
Xia	NULL
,	NULL
Man	NULL
Jiang	NULL
,	NULL
Sangjin	NULL
Lee	NULL
and	NULL
Alessandra	NULL
B.	NULL
Pernis	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:5997-6004	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/11/5997	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
63	NULL
articles	NULL
,	NULL
33	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/11/5997.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Signaling	NULL
Pathways	NULL
Mediated	NULL
by	NULL
the	NULL
TNF-	NULL
and	NULL
Cytokine-Receptor	NULL
Families	NULL
Target	NULL
a	NULL
Common	NULL
cis-Element	NULL
of	NULL
the	NULL
IFN	NULL
Regulatory	NULL
Factor	NULL
1	NULL
Promoter	NULL
Sanjay	NULL
Gupta	NULL
,	NULL
Dengfeng	NULL
Xia	NULL
,	NULL
Man	NULL
Jiang	NULL
,	NULL
Sangjin	NULL
Lee	NULL
,	NULL
and	NULL
Alessandra	NULL
B.	NULL
Pernis®	NULL
CD40	NULL
activation	NULL
of	NULL
B	NULL
cells	NULL
is	NULL
strongly	NULL
influenced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
cytokines	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
interplay	NULL
between	NULL
these	NULL
distinct	NULL
stimuli	NULL
is	NULL
not	NULL
clearly	NULL
delineated	NULL
.	NULL

IFN	NULL
regulatory	NULL
factor	NULL
1	NULL
(	NULL
IRF-1	NULL
)	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
activated	NULL
by	NULL
either	NULL
CD40	NULL
or	NULL
cytokines	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
these	NULL
different	NULL
sets	NULL
of	NULL
signals	NULL
target	NULL
a	NULL
common	NULL
cis-acting	NULL
element	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
this	NULL
gene	NULL
,	NULL
the	NULL
IRF-1	NULL
gamma-activated	NULL
site	NULL
(	NULL
GAS	NULL
)	NULL
.	NULL

Targeting	NULL
of	NULL
the	NULL
IRF-1	NULL
GAS	NULL
is	NULL
not	NULL
confined	NULL
to	NULL
activation	NULL
via	NULL
CD40	NULL
but	NULL
extends	NULL
to	NULL
other	NULL
stimuli	NULL
that	NULL
mimic	NULL
the	NULL
CD40	NULL
signaling	NULL
cascade	NULL
,	NULL
like	NULL
TNF-a	NULL
and	NULL
EBV	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
induction	NULL
of	NULL
STATs	NULL
by	NULL
cytokines	NULL
,	NULL
the	NULL
IRF-1	NULL
GAS-binding	NULL
complex	NULL
activated	NULL
by	NULL
CD40	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
EBV	NULL
contains	NULL
Rel	NULL
proteins	NULL
,	NULL
specifically	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

In	NULL
this	NULL
system	NULL
,	NULL
simultaneous	NULL
exposure	NULL
to	NULL
CD4O0L	NULL
together	NULL
with	NULL
either	NULL
IL-4	NULL
or	NULL
IFN-y	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
novel	NULL
Re/STAT	NULL
complexes	NULL
.	NULL

Given	NULL
the	NULL
importance	NULL
of	NULL
IRF-1	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
biologic	NULL
functions	NULL
from	NULL
proliferation	NULL
to	NULL
apoptosis	NULL
,	NULL
our	NULL
findings	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
modulation	NULL
of	NULL
IRF-1	NULL
levels	NULL
may	NULL
be	NULL
a	NULL
critical	NULL
control	NULL
point	NULL
in	NULL
B	NULL
cell	NULL
activation	NULL
.	NULL

5997-6004.	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
shaping	NULL
the	NULL
proliferative	NULL
and	NULL
dif-	NULL
ferentiative	NULL
outcomes	NULL
of	NULL
B	NULL
cells	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
B	NULL
cells	NULL
by	NULL
CD40	NULL
cross-linking	NULL
is	NULL
significantly	NULL
enhanced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
cytokines	NULL
,	NULL
in	NULL
particular	NULL
IL-4	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
basis	NULL
underlying	NULL
the	NULL
cross-talk	NULL
between	NULL
CD40-	NULL
and	NULL
cytokine-mediated	NULL
signaling	NULL
pathways	NULL
has	NULL
not	NULL
been	NULL
clearly	NULL
delineated	NULL
.	NULL

CD40	NULL
shares	NULL
structural	NULL
and	NULL
functional	NULL
features	NULL
with	NULL
members	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
of	NULL
receptors	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Despite	NULL
significant	NULL
sequence	NULL
divergence	NULL
within	NULL
their	NULL
intracytoplasmic	NULL
domain	NULL
,	NULL
distinct	NULL
members	NULL
of	NULL
this	NULL
family	NULL
of	NULL
receptors	NULL
signal	NULL
through	NULL
similar	NULL
components	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
many	NULL
of	NULL
these	NULL
receptors	NULL
associate	NULL
with	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
termed	NULL
TRAFs	NULL
(	NULL
TNFR-associated	NULL
factors	NULL
)	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Discovery	NULL
of	NULL
this	NULL
family	NULL
of	NULL
molecules	NULL
has	NULL
revealed	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
EBV	NULL
to	NULL
successfully	NULL
immortalize	NULL
human	NULL
B	NULL
cells	NULL
may	NULL
rely	NULL
,	NULL
in	NULL
part	NULL
,	NULL
on	NULL
the	NULL
capacity	NULL
of	NULL
one	NULL
of	NULL
the	NULL
viral	NULL
proteins	NULL
,	NULL
Latent	NULL
membrane	NULL
protein	NULL
1	NULL
,	NULL
to	NULL
associate	NULL
with	NULL
TRAF	NULL
molecules	NULL
and	NULL
thus	NULL
constitutively	NULL
activate	NULL
the	NULL
CD40	NULL
signaling	NULL
pathway	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
TRAFs	NULL
,	NULL
CD40	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
of	NULL
receptors	NULL
also	NULL
activate	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
9	NULL
,	NULL
11-13	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
many	NULL
genes	NULL
critical	NULL
to	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

The	NULL
generation	NULL
of	NULL
mice	NULL
lacking	NULL
individual	NULL
Rel	NULL
family	NULL
members	NULL
has	NULL
indicated	NULL
that	NULL
many	NULL
Rel	NULL
pro	NULL
T	NULL
he	NULL
interaction	NULL
between	NULL
CD40	NULL
and	NULL
its	NULL
ligand	NULL
(	NULL
CD4O0L	NULL
)	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10032	NULL
Received	NULL
for	NULL
publication	NULL
January	NULL
20	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
August	NULL
6	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
Grant-in	NULL
Aid	NULL
from	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
,	NULL
the	NULL
Silverberger	NULL
Award	NULL
,	NULL
and	NULL
the	NULL
Arthur	NULL
N.	NULL
Saydman	NULL
Investigatorship	NULL
in	NULL
Septicemia	NULL
Research	NULL
.	NULL

In	NULL
honor	NULL
of	NULL
Dr.	NULL
Harold	NULL
C.	NULL
Neu	NULL
2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Alessandra	NULL
Pernis	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
630	NULL
West	NULL
168th	NULL
Street	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10032	NULL
.	NULL

3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CD4O0L	NULL
,	NULL
CD40	NULL
ligand	NULL
;	NULL
TRAF	NULL
,	NULL
TNFR-associated	NULL
factor	NULL
;	NULL
ko	NULL
,	NULL
knockout	NULL
;	NULL
GAS	NULL
,	NULL
gamma-activated	NULL
sites	NULL
;	NULL
IRF	NULL
,	NULL
IFN	NULL
regulatory	NULL
factor	NULL
;	NULL
tx	NULL
,	NULL
transfectant	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
WCE	NULL
,	NULL
whole	NULL
cell	NULL
extract	NULL
;	NULL
TPCK	NULL
,	NULL
N-tosyl-L-phenylalanine	NULL
chloromethyl	NULL
ketone	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
teins	NULL
serve	NULL
specific	NULL
nonredundant	NULL
immunologic	NULL
functions	NULL
(	NULL
14	NULL
)	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
B	NULL
cells	NULL
from	NULL
the	NULL
p50	NULL
knockout	NULL
(	NULL
ko	NULL
)	NULL
are	NULL
unable	NULL
to	NULL
switch	NULL
to	NULL
specific	NULL
isotypes	NULL
,	NULL
while	NULL
their	NULL
proliferative	NULL
responses	NULL
to	NULL
anti-CD40	NULL
Abs	NULL
are	NULL
intact	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
B	NULL
cells	NULL
from	NULL
the	NULL
RelB	NULL
ko	NULL
demonstrate	NULL
defective	NULL
proliferative	NULL
responses	NULL
to	NULL
CD40	NULL
stimulation	NULL
,	NULL
but	NULL
undergo	NULL
normal	NULL
Ig	NULL
class	NULL
switching	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
different	NULL
Rel	NULL
family	NULL
members	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
distinct	NULL
signaling	NULL
pathways	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
.	NULL

Recruitment	NULL
of	NULL
similar	NULL
signaling	NULL
components	NULL
by	NULL
different	NULL
members	NULL
of	NULL
a	NULL
family	NULL
of	NULL
receptors	NULL
is	NULL
also	NULL
a	NULL
well-known	NULL
feature	NULL
of	NULL
the	NULL
cytokine	NULL
receptor	NULL
superfamily	NULL
,	NULL
which	NULL
includes	NULL
IL-4R	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
receptors	NULL
signal	NULL
by	NULL
following	NULL
the	NULL
paradigm	NULL
originally	NULL
described	NULL
for	NULL
the	NULL
IFN	NULL
signal	NULL
transduction	NULL
pathway	NULL
(	NULL
20	NULL
)	NULL
.	NULL

This	NULL
pathway	NULL
involves	NULL
the	NULL
activation	NULL
,	NULL
via	NULL
JAK	NULL
kinases	NULL
,	NULL
of	NULL
latent	NULL
cytoplasmic	NULL
proteins	NULL
belonging	NULL
to	NULL
the	NULL
STAT	NULL
family	NULL
of	NULL
proteins	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
STATs	NULL
allows	NULL
them	NULL
to	NULL
associate	NULL
in	NULL
complexes	NULL
that	NULL
can	NULL
then	NULL
translocate	NULL
into	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
modulate	NULL
gene	NULL
transcription	NULL
by	NULL
binding	NULL
to	NULL
distinct	NULL
DNA	NULL
elements	NULL
termed	NULL
GAS	NULL
(	NULL
gamma-activated	NULL
sites	NULL
)	NULL
.	NULL

Unlike	NULL
other	NULL
GAS	NULL
elements	NULL
,	NULL
the	NULL
GAS	NULL
in	NULL
the	NULL
IFN	NULL
regulatory	NULL
factor	NULL
1	NULL
(	NULL
IRF-1	NULL
)	NULL
promoter	NULL
displays	NULL
high-affinity	NULL
binding	NULL
for	NULL
STAT	NULL
complexes	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
cytokines	NULL
(	NULL
21-23	NULL
)	NULL
.	NULL

IRF-1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
growing	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
whose	NULL
members	NULL
bind	NULL
a	NULL
related	NULL
enhancer	NULL
but	NULL
impart	NULL
contrasting	NULL
effects	NULL
on	NULL
the	NULL
transactivation	NULL
of	NULL
genes	NULL
(	NULL
24	NULL
)	NULL
.	NULL

For	NULL
exam-ple	NULL
,	NULL
the	NULL
ratio	NULL
of	NULL
IRF-1	NULL
and	NULL
another	NULL
IRF	NULL
member	NULL
,	NULL
IRF-2	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cellular	NULL
proliferation	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
IRF-1	NULL
is	NULL
involved	NULL
in	NULL
apoptosis	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
development	NULL
and	NULL
function	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
immune	NULL
effector	NULL
cells	NULL
(	NULL
28-32	NULL
)	NULL
.	NULL

We	NULL
have	NULL
been	NULL
interested	NULL
in	NULL
understanding	NULL
the	NULL
cross-talk	NULL
between	NULL
CD40	NULL
and	NULL
cytokine	NULL
signaling	NULL
pathways	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
signals	NULL
triggered	NULL
by	NULL
CD40	NULL
,	NULL
or	NULL
by	NULL
stimuli	NULL
that	NULL
mimic	NULL
the	NULL
CD40	NULL
signaling	NULL
cascade	NULL
,	NULL
like	NULL
TNF-a	NULL
and	NULL
EBV	NULL
,	NULL
activate	NULL
complexes	NULL
that	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
GAS	NULL
element	NULL
of	NULL
the	NULL
IRF-1	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
the	NULL
IRF-1	NULL
GAS-binding	NULL
complexes	NULL
activated	NULL
by	NULL
CD40	NULL
,	NULL
TNF-	NULL
@	NULL
,	NULL
and	NULL
EBV	NULL
do	NULL
not	NULL
contain	NULL
known	NULL
STAT	NULL
complexes	NULL
but	NULL
employ	NULL
0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5998	NULL
members	NULL
of	NULL
the	NULL
Rel/NF-	NULL
«	NULL
B	NULL
family	NULL
,	NULL
specifically	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

Targeting	NULL
of	NULL
a	NULL
common	NULL
cis-acting	NULL
element	NULL
by	NULL
different	NULL
pathways	NULL
may	NULL
thus	NULL
allow	NULL
a	NULL
cell	NULL
to	NULL
integrate	NULL
multiple	NULL
incoming	NULL
signals	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
lines	NULL
The	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
Ramos	NULL
(	NULL
obtained	NULL
from	NULL
Dr.	NULL
Seth	NULL
Lederman	NULL
,	NULL
Columbia	NULL
University	NULL
)	NULL
,	NULL
BL-2	NULL
,	NULL
and	NULL
BJAB	NULL
cells	NULL
(	NULL
obtained	NULL
from	NULL
Dr.	NULL
Riccardo	NULL
Dalla-Favera	NULL
,	NULL
Columbia	NULL
University	NULL
)	NULL
are	NULL
EBV-negative	NULL
Burkitt	NULL
's	NULL
lympho-mas	NULL
.	NULL

WIL-2-729HF2	NULL
(	NULL
WIL-2	NULL
;	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Man-assas	NULL
,	NULL
VA	NULL
)	NULL
and	NULL
JY	NULL
(	NULL
obtained	NULL
from	NULL
Dr.	NULL
Riccardo	NULL
Dalla-Favera	NULL
,	NULL
Columbia	NULL
University	NULL
)	NULL
are	NULL
EBV	NULL
-transformed	NULL
lymphoblastoid	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

THP-1	NULL
(	NULL
obtained	NULL
from	NULL
Dr.	NULL
Kathryne	NULL
Calame	NULL
,	NULL
Columbia	NULL
University	NULL
)	NULL
is	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
Atlanta	NULL
Biologicals	NULL
,	NULL
Norcross	NULL
,	NULL
GA	NULL
)	NULL
.	NULL

293	NULL
cells	NULL
stably	NULL
transfected	NULL
either	NULL
with	NULL
CD4O0L	NULL
(	NULL
CD4O0L	NULL
tx	NULL
)	NULL
or	NULL
CD8	NULL
(	NULL
CD8	NULL
tx	NULL
)	NULL
were	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr.	NULL
Seth	NULL
Lederman	NULL
(	NULL
Columbia	NULL
University	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Their	NULL
derivation	NULL
and	NULL
culture	NULL
conditions	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

DNA-binding	NULL
assays	NULL
and	NULL
cell	NULL
extracts	NULL
The	NULL
preparation	NULL
and	NULL
employment	NULL
of	NULL
DNA	NULL
oligonucleotide	NULL
probes	NULL
for	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
IRF-1	NULL
GAS	NULL
probe	NULL
employed	NULL
in	NULL
these	NULL
studies	NULL
was	NULL
as	NULL
follows	NULL
:	NULL
5'-gatcGATTTCCCGAAAT-3	NULL
'	NULL
.	NULL

The	NULL
ISG-15	NULL
interferon-stimulated	NULL
response	NULL
element	NULL
probe	NULL
was	NULL
as	NULL
follows	NULL
:	NULL
5'-gatcCTCGGGAAAGGGAA	NULL
ACCGAAACTGAAGCC	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
used	NULL
as	NULL
cold	NULL
competitors	NULL
were	NULL
prepared	NULL
from	NULL
single-stranded	NULL
oligonucleotides	NULL
(	NULL
Life	NULL
Tech-nologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
with	NULL
the	NULL
following	NULL
sequences	NULL
:	NULL
B-CAS	NULL
GAS	NULL
(	NULL
5'-gatcGACTTCITGGAATT-3	NULL
``	NULL
)	NULL
(	NULL
21	NULL
)	NULL
,	NULL
Ie	NULL
GAS	NULL
(	NULL
-119	NULL
to	NULL
-104	NULL
)	NULL
(	NULL
5'-gatcAA	NULL
CTTCCCAAGAACAG-3	NULL
``	NULL
)	NULL
(	NULL
21	NULL
)	NULL
,	NULL
ICAM-1	NULL
GAS	NULL
(	NULL
5	NULL
``	NULL
-gatecGGTTTCCGGGAA	NULL
AGC-3	NULL
``	NULL
)	NULL
(	NULL
33	NULL
)	NULL
,	NULL
CD23a	NULL
GAS	NULL
(	NULL
5	NULL
GAG-3	NULL
'	NULL
)	NULL
(	NULL
34	NULL
)	NULL
,	NULL
CD23b	NULL
GAS	NULL
(	NULL
5'-gatcGGGTGAATTTCTAAGAAAGGGAC-3	NULL
``	NULL
)	NULL
(	NULL
34	NULL
)	NULL
,	NULL
IL-2Ra	NULL
NF-KB	NULL
(	NULL
5'-gatecCAGGGGAATCTCCCT-3	NULL
'	NULL
)	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
5'-gatcCTGGGGACTTTCCAGG-3	NULL
'	NULL
)	NULL
(	NULL
35	NULL
)	NULL
.	NULL

STAT	NULL
or	NULL
Rel	NULL
antisera	NULL
were	NULL
added	NULL
(	NULL
final	NULL
dilution	NULL
1:20	NULL
)	NULL
for	NULL
30-60	NULL
min	NULL
(	NULL
at	NULL
4°C	NULL
)	NULL
,	NULL
before	NULL
a	NULL
standard	NULL
20	NULL
min	NULL
(	NULL
at	NULL
25°C	NULL
)	NULL
incubation	NULL
of	NULL
extracts	NULL
with	NULL
the	NULL
DNA	NULL
probe	NULL
.	NULL

Oligonucleotide	NULL
competitions	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
for	NULL
15	NULL
min	NULL
(	NULL
at	NULL
25°C	NULL
)	NULL
before	NULL
standard	NULL
20	NULL
min	NULL
(	NULL
at	NULL
25°C	NULL
)	NULL
incubation	NULL
of	NULL
extracts	NULL
with	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
(	NULL
WCE	NULL
)	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Extracts	NULL
from	NULL
IL-3-treated	NULL
FDtrk	NULL
and	NULL
IL-6-treated	NULL
HepG-2	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr.	NULL
Chris	NULL
Schindler	NULL
(	NULL
Columbia	NULL
University	NULL
)	NULL
.	NULL

Antibodies	NULL
Polyclonal	NULL
rabbit	NULL
antisera	NULL
against	NULL
Statl	NULL
and	NULL
Stat	NULL
?	NULL

were	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr.	NULL
Chris	NULL
Schindler	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
antisera	NULL
against	NULL
human	NULL
Stat3	NULL
,	NULL
Stat5	NULL
,	NULL
and	NULL
Stat6	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
Polyclonal	NULL
rabbit	NULL
antisera	NULL
against	NULL
the	NULL
Rel	NULL
proteins	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
RelB	NULL
,	NULL
p52	NULL
were	NULL
also	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
Purified	NULL
anti-CD40	NULL
mAb	NULL
G28-5	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr.	NULL
Seth	NULL
Lederman	NULL
.	NULL

The	NULL
isotype	NULL
matched	NULL
control	NULL
mAb	NULL
was	NULL
purchased	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
Ramos	NULL
B	NULL
cells	NULL
(	NULL
50-80	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
added	NULL
to	NULL
plates	NULL
containing	NULL
CD4OL	NULL
tx	NULL
or	NULL
CD8	NULL
tx	NULL
cells	NULL
(	NULL
20	NULL
X	NULL
10°	NULL
and	NULL
then	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
varying	NULL
periods	NULL
of	NULL
times	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
10	NULL
ml	NULL
.	NULL

Coculture	NULL
with	NULL
other	NULL
cell	NULL
lines	NULL
followed	NULL
the	NULL
same	NULL
protocol	NULL
.	NULL

Cytokine	NULL
treatments	NULL
were	NULL
conducted	NULL
simultaneously	NULL
in	NULL
separate	NULL
plates	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
10	NULL
ml	NULL
utilizing	NULL
the	NULL
following	NULL
cytokine	NULL
concentrations	NULL
:	NULL
human	NULL
IL-4	NULL
(	NULL
100	NULL
U/ml	NULL
;	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr.	NULL
Paul	NULL
Rothman	NULL
,	NULL
Columbia	NULL
University	NULL
)	NULL
,	NULL
human	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
PeproTech	NULL
,	NULL
Rocky	NULL
Hill	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
human	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/ml	NULL
;	NULL
PeproTech	NULL
)	NULL
,	NULL
and	NULL
human	NULL
IFN-	NULL
(	NULL
100	NULL
U/ml	NULL
;	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr.	NULL
Chris	NULL
Schindler	NULL
)	NULL
.	NULL

In	NULL
experiments	NULL
where	NULL
Ramos	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD40	NULL
mAb	NULL
,	NULL
20	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
1	NULL
pg/ml	NULL
of	NULL
Ab	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
2	NULL
ml	NULL
.	NULL

Treatment	NULL
of	NULL
Ramos	NULL
cells	NULL
with	NULL
TPCK	NULL
(	NULL
N-tosyl-L-phenylalanine	NULL
chloromethyl	NULL
ketone	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
50	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
25	NULL
pg	NULL
of	NULL
TPCK	NULL
for	NULL
1	NULL
h	NULL
before	NULL
incubation	NULL
with	NULL
either	NULL
CD40L	NULL
or	NULL
CD8	NULL
tx	NULL
for	NULL
2	NULL
h.	NULL
Treatment	NULL
with	NULL
cycloheximide	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

UV	NULL
cross-linking	NULL
UV	NULL
cross-linking	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
37	NULL
)	NULL
except	NULL
that	NULL
the	NULL
gel	NULL
shift	NULL
reactions	NULL
were	NULL
conducted	NULL
at	NULL
25°C	NULL
and	NULL
irradiated	NULL
twice	NULL
with	NULL
CONVERGENCE	NULL
OF	NULL
SIGNALS	NULL
BY	NULL
TNF-	NULL
AND	NULL
CYTOKINE-RECEPTOR	NULL
FAMILIES	NULL
1000	NULL
mJ	NULL
of	NULL
UV	NULL
administered	NULL
with	NULL
a	NULL
Stratalinker	NULL
(	NULL
Ultra-violet	NULL
Products	NULL
,	NULL
Cambridge	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Cross-linked	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
immunoprecipitated	NULL
using	NULL
either	NULL
a	NULL
p65	NULL
or	NULL
a	NULL
Stat3	NULL
antiserum	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
then	NULL
fractionated	NULL
on	NULL
a	NULL
7	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
an	NULL
x-ray	NULL
film	NULL
.	NULL

Reactions	NULL
not	NULL
exposed	NULL
to	NULL
UV	NULL
cross-linking	NULL
were	NULL
simultaneously	NULL
conducted	NULL
as	NULL
negative	NULL
controls	NULL
.	NULL

Northern	NULL
analysis	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
by	NULL
using	NULL
the	NULL
Ultra-Spec	NULL
II	NULL
kit	NULL
(	NULL
Biotecx	NULL
Labora-tories	NULL
,	NULL
Houston	NULL
TX	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
10	NULL
pug	NULL
of	NULL
total	NULL
RNA	NULL
according	NULL
to	NULL
standard	NULL
protocols	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
either	NULL
a	NULL
human	NULL
IRF-1	NULL
cDNA	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Richard	NULL
Pine	NULL
)	NULL
or	NULL
a	NULL
glycer-aldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
cDNA	NULL
radiolabeled	NULL
with	NULL
the	NULL
Pharmacia	NULL
DNA	NULL
Labelling	NULL
beads	NULL
(	NULL
-dCTP	NULL
)	NULL
kit	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Pis-cataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Results	NULL
Induction	NULL
of	NULL
an	NULL
IRF-1	NULL
GAS-binding	NULL
complex	NULL
by	NULL
CD40	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
or	NULL
EBV	NULL
To	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
CD40	NULL
stimulation	NULL
on	NULL
cytokine	NULL
signaling	NULL
pathways	NULL
,	NULL
we	NULL
cocultured	NULL
cells	NULL
from	NULL
Ramos	NULL
,	NULL
an	NULL
EBV-negative	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
together	NULL
with	NULL
293	NULL
cells	NULL
stably	NULL
transfected	NULL
either	NULL
with	NULL
human	NULL
CD4O0L	NULL
(	NULL
CD4OL	NULL
tx	NULL
)	NULL
or	NULL
with	NULL
CD8	NULL
(	NULL
CDS	NULL
tx	NULL
)	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
(	NULL
8	NULL
)	NULL
.	NULL

After	NULL
harvesting	NULL
the	NULL
cells	NULL
,	NULL
we	NULL
prepared	NULL
whole	NULL
cell	NULL
extracts	NULL
and	NULL
assayed	NULL
them	NULL
by	NULL
EMSA	NULL
using	NULL
as	NULL
a	NULL
probe	NULL
the	NULL
GAS	NULL
element	NULL
from	NULL
the	NULL
IRF-1	NULL
promoter	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
used	NULL
this	NULL
site	NULL
to	NULL
detect	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
STAT	NULL
complexes	NULL
in	NULL
response	NULL
to	NULL
different	NULL
cytokines	NULL
(	NULL
21	NULL
)	NULL
.	NULL

A	NULL
functional	NULL
CD40/CD40L	NULL
interaction	NULL
was	NULL
confirmed	NULL
by	NULL
detecting	NULL
CD23	NULL
up-regulation	NULL
via	NULL
FACS	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
revealed	NULL
that	NULL
stimulation	NULL
of	NULL
Ramos	NULL
cells	NULL
with	NULL
CD4O0L	NULL
tx	NULL
but	NULL
not	NULL
with	NULL
CD8	NULL
tx	NULL
led	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
novel	NULL
DNA-binding	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
using	NULL
an	NULL
Ab	NULL
to	NULL
CD40	NULL
(	NULL
G28-5	NULL
)	NULL
rather	NULL
than	NULL
the	NULL
CD4OL	NULL
transfectants	NULL
,	NULL
confirming	NULL
that	NULL
induction	NULL
of	NULL
this	NULL
complex	NULL
was	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
the	NULL
CD4O0/CDA4OL	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
this	NULL
€CD4O-inducible	NULL
complex	NULL
was	NULL
observed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
BL-2	NULL
,	NULL
BJAB	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
respond	NULL
to	NULL
CD40	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
both	NULL
TNF-a	NULL
and	NULL
EBV	NULL
utilize	NULL
signaling	NULL
pathways	NULL
similar	NULL
to	NULL
those	NULL
triggered	NULL
by	NULL
CD40	NULL
,	NULL
a	NULL
comparable	NULL
IRF-1	NULL
GAS-binding	NULL
complex	NULL
was	NULL
observed	NULL
upon	NULL
stimulation	NULL
of	NULL
Ramos	NULL
cells	NULL
with	NULL
TNF-a	NULL
@	NULL
or	NULL
constitutively	NULL
in	NULL
EBV	NULL
transformed	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
WIL-2	NULL
and	NULL
JY	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Kinetic	NULL
experiments	NULL
revealed	NULL
that	NULL
both	NULL
CD40-	NULL
and	NULL
ducible	NULL
complexes	NULL
were	NULL
activated	NULL
within	NULL
15	NULL
min	NULL
after	NULL
the	NULL
stimulation	NULL
of	NULL
Ramos	NULL
cells	NULL
and	NULL
lasted	NULL
up	NULL
to	NULL
48	NULL
h.	NULL
Coculturing	NULL
Ramos	NULL
cells	NULL
with	NULL
CD4OL	NULL
transfectants	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
enhanced	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
an	NULL
antiphosphotyrosine	NULL
Ab	NULL
to	NULL
the	NULL
EMSA	NULL
reactions	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
appearance	NULL
of	NULL
this	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
utilization	NULL
of	NULL
related	NULL
signaling	NULL
pathways	NULL
by	NULL
CD40	NULL
,	NULL
TNF-	NULL
@	NULL
,	NULL
and	NULL
EBV	NULL
is	NULL
reflected	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
similar	NULL
DNA-binding	NULL
complexes	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
rapid	NULL
activation	NULL
of	NULL
these	NULL
factors	NULL
as	NULL
well	NULL
as	NULL
their	NULL
resistance	NULL
to	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
suggest	NULL
that	NULL
these	NULL
complexes	NULL
are	NULL
composed	NULL
of	NULL
latent	NULL
cytoplasmic	NULL
factors	NULL
.	NULL

The	NULL
CD4O0-	NULL
,	NULL
TNF-a	NULL
@	NULL
-	NULL
,	NULL
and	NULL
EBV-inducible	NULL
complexes	NULL
binding	NULL
to	NULL
the	NULL
IRF-1	NULL
GAS	NULL
do	NULL
not	NULL
contain	NULL
known	NULL
STAT	NULL
complexes	NULL
Although	NULL
some	NULL
GAS	NULL
elements	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
the	NULL
IRF-1	NULL
and	NULL
B-CAS	NULL
GAS	NULL
)	NULL
can	NULL
bind	NULL
a	NULL
variety	NULL
of	NULL
STAT	NULL
complexes	NULL
,	NULL
other	NULL
GAS	NULL
sequences	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
the	NULL
Ie	NULL
GAS	NULL
)	NULL
exhibit	NULL
exquisite	NULL
specificity	NULL
for	NULL
distinct	NULL
STAT	NULL
complexes	NULL
(	NULL
21	NULL
)	NULL
.	NULL

To	NULL
begin	NULL
delineating	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
GAS-binding	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
anti-CD40	NULL
Mab	NULL
control	NULL
Mab	NULL
CD4O0L	NULL
tx	NULL
control	NULL
tx	NULL
control	NULL
tx	NULL
CD40L	NULL
tx	NULL
control	NULL
tx	NULL
IL-4	NULL
P	NULL
3	NULL
Eo	NULL
¢	NULL
moos	NULL
:	NULL
cosol	NULL
tx	NULL
¥	NULL
\-	NULL
ton	NULL
RAMOS	NULL
BL-2	NULL
THP-1	NULL
anti-CD40	NULL
Mab	NULL
control	NULL
Mab	NULL
TNF-a	NULL
.	NULL

sA	NULL
ban	NULL
RAMOS	NULL
W	NULL
JY	NULL
FIGURE	NULL
1	NULL
.	NULL

A	NULL
,	NULL
Induction	NULL
of	NULL
IRF-1	NULL
GAS-binding	NULL
activities	NULL
in	NULL
Ramos	NULL
,	NULL
BL-2	NULL
,	NULL
or	NULL
THP-1	NULL
cells	NULL
by	NULL
CD40	NULL
stimulation	NULL
.	NULL

WCE	NULL
were	NULL
prepared	NULL
from	NULL
Ramos	NULL
or	NULL
BL-2	NULL
with	NULL
or	NULL
without	NULL
a	NULL
24-h	NULL
stimulation	NULL
at	NULL
37°C	NULL
with	NULL
CD4OL	NULL
transfectants	NULL
(	NULL
tx	NULL
)	NULL
vs	NULL
control	NULL
transfectants	NULL
.	NULL

Ramos	NULL
cells	NULL
were	NULL
also	NULL
separately	NULL
stimulated	NULL
with	NULL
either	NULL
an	NULL
anti-CD40	NULL
mAb	NULL
(	NULL
G28-5	NULL
)	NULL
at	NULL
1	NULL
pg/ml	NULL
or	NULL
a	NULL
control	NULL
mAb	NULL
.	NULL

WCE	NULL
from	NULL
IL-4-treated	NULL
Ramos	NULL
cells	NULL
were	NULL
included	NULL
as	NULL
a	NULL
control	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
45	NULL
min	NULL
with	NULL
either	NULL
CD4O0L	NULL
or	NULL
control	NULL
tx	NULL
.	NULL

The	NULL
WCE	NULL
were	NULL
examined	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
*°P-labeled	NULL
IRF-1	NULL
GAS	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
Comparison	NULL
of	NULL
IRF-1	NULL
GAS-binding	NULL
activities	NULL
induced	NULL
in	NULL
Ramos	NULL
cells	NULL
by	NULL
CD40	NULL
or	NULL
TNF-a	NULL
«	NULL
stimulation	NULL
vs	NULL
those	NULL
constitutively	NULL
detected	NULL
in	NULL
EBV-transformed	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
WIL-2	NULL
,	NULL
JY	NULL
)	NULL
.	NULL

WCE	NULL
were	NULL
prepared	NULL
from	NULL
Ramos	NULL
cells	NULL
with	NULL
or	NULL
without	NULL
a	NULL
24-h	NULL
stimulation	NULL
at	NULL
37°C	NULL
with	NULL
either	NULL
an	NULL
anti-CD40	NULL
mAb	NULL
(	NULL
G28-5	NULL
)	NULL
at	NULL
1	NULL
ug/ml	NULL
,	NULL
a	NULL
control	NULL
mAb	NULL
,	NULL
or	NULL
human	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
.	NULL

WCE	NULL
were	NULL
simultaneously	NULL
obtained	NULL
from	NULL
untreated	NULL
WIL-2	NULL
(	NULL
W	NULL
)	NULL
or	NULL
JY	NULL
cells	NULL
.	NULL

The	NULL
WCE	NULL
were	NULL
assayed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

complex	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
or	NULL
TNF-	NULL
@	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
experiments	NULL
using	NULL
a	NULL
panel	NULL
of	NULL
different	NULL
GAS	NULL
elements	NULL
(	NULL
21	NULL
)	NULL
as	NULL
cold	NULL
competitors	NULL
of	NULL
the	NULL
radiolabeled	NULL
IRF-1	NULL
GAS	NULL
probe	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
Ie	NULL
GAS	NULL
and	NULL
the	NULL
ICAM-1	NULL
GAS	NULL
are	NULL
derived	NULL
from	NULL
the	NULL
promoters	NULL
of	NULL
CD40-	NULL
and/or	NULL
TNF-a-responsive	NULL
genes	NULL
,	NULL
neither	NULL
of	NULL
these	NULL
elements	NULL
competed	NULL
for	NULL
the	NULL
complex	NULL
induced	NULL
by	NULL
CD40	NULL
or	NULL
TNF-	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

As	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
,	NULL
these	NULL
elements	NULL
adequately	NULL
competed	NULL
for	NULL
the	NULL
IL-4-inducible	NULL
Stat6	NULL
homodimer	NULL
(	NULL
34	NULL
,	NULL
38-40	NULL
)	NULL
and/or	NULL
the	NULL
IFN-y-inducible	NULL
Statl	NULL
homodimer	NULL
(	NULL
41	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5999	NULL
A	NULL
g	NULL
0	NULL
$	NULL
80	NULL
:	NULL
$	NULL
Km	NULL
i	NULL
o	NULL
winn	NULL
scas	NULL
cas	NULL
mome	NULL
cant	NULL
cas	NULL
RAMOS	NULL
+	NULL
RAMOS+	NULL
RAMOS	NULL
+	NULL
CD40L	NULL
tx	NULL
IFN-y	NULL
IL-4	NULL
COMP	NULL
.	NULL

|§§1§§|§§	NULL
HIT	NULL
]	NULL
AL	NULL
.	NULL

B	NULL
®	NULL
RAMOS+	NULL
RAMOS+	NULL
RAMOS+	NULL
CD40L	NULL
tx	NULL
_	NULL
IL-4	NULL
IFN-y	NULL
FIGURE	NULL
2	NULL
.	NULL

Comparison	NULL
of	NULL
IRF-1	NULL
GAS-binding	NULL
activities	NULL
induced	NULL
by	NULL
CD40	NULL
,	NULL
IFN-y	NULL
,	NULL
or	NULL
IL-4	NULL
stimulation	NULL
by	NULL
GAS	NULL
oligonucleotide	NULL
competition	NULL
.	NULL

A	NULL
,	NULL
Ramos	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
CD4OL	NULL
tx	NULL
,	NULL
human	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
human	NULL
IL-4	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Oligonucleotide	NULL
competition	NULL
assays	NULL
were	NULL
performed	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
GAS	NULL
oligonucleotides	NULL
added	NULL
to	NULL
the	NULL
shift	NULL
reaction	NULL
as	NULL
indicated	NULL
.	NULL

Competitors	NULL
included	NULL
Ie-GAS	NULL
,	NULL
BCAS-GAS	NULL
,	NULL
ICAM1-	NULL
GAS	NULL
,	NULL
or	NULL
IRF-1	NULL
GAS	NULL
.	NULL

B	NULL
,	NULL
Ramos	NULL
cells	NULL
were	NULL
cultured	NULL
and	NULL
assayed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Competitors	NULL
included	NULL
the	NULL
CD23a	NULL
GAS	NULL
and	NULL
the	NULL
CD23b	NULL
GAS	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
distinctive	NULL
competition	NULL
pattern	NULL
displayed	NULL
by	NULL
the	NULL
CD4O0-inducible	NULL
complex	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
this	NULL
complex	NULL
might	NULL
not	NULL
contain	NULL
known	NULL
STAT	NULL
complexes	NULL
.	NULL

Another	NULL
CD40	NULL
target	NULL
gene	NULL
,	NULL
CD23	NULL
,	NULL
exists	NULL
as	NULL
two	NULL
different	NULL
iso-forms	NULL
,	NULL
CD23a	NULL
and	NULL
CD23b	NULL
,	NULL
whose	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
separate	NULL
promoters	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
promoters	NULL
contain	NULL
GAS	NULL
elements	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
these	NULL
GAS	NULL
elements	NULL
were	NULL
tested	NULL
,	NULL
only	NULL
the	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
CD23b	NULL
GAS	NULL
was	NULL
able	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
CD4O0-inducible	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
this	NULL
selective	NULL
effect	NULL
,	NULL
both	NULL
the	NULL
CD23a	NULL
and	NULL
CD23b	NULL
GAS	NULL
blocked	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
IL-4-inducible	NULL
Stat6	NULL
homodimer	NULL
,	NULL
while	NULL
neither	NULL
the	NULL
CD23a	NULL
GAS	NULL
nor	NULL
the	NULL
CD23b	NULL
GAS	NULL
affected	NULL
the	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Oligonucleotides	NULL
used	NULL
in	NULL
competition	NULL
analysis	NULL
Oligonucleotide	NULL
Sequence	NULL
(	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
)	NULL
Competition	NULL
GAS	NULL
IRF-1	NULL
GAS	NULL
TTTC	NULL
GGGG	NULL
AAAT	NULL
CA	NULL
+	NULL
le	NULL
GAS	NULL
TTCC	NULL
CAAG	NULL
AACA	NULL
GA	NULL
B-CAS	NULL
GAS	NULL
CTTC	NULL
TTGG	NULL
AATT	NULL
CA	NULL
ICAM-1	NULL
GAS	NULL
TTTC	NULL
CGGG	NULL
AAAG	NULL
CA	NULL
CD23a	NULL
GAS	NULL
CC	NULL
AATT	NULL
CTCT	NULL
TACC	NULL
TGAG	NULL
AAAT	NULL
GGAG	NULL
CD23b	NULL
GAS	NULL
GGG	NULL
TGAA	NULL
TITC	NULL
TAAG	NULL
AAAG	NULL
GGAC	NULL
+	NULL
NF-	NULL
«	NULL
B	NULL
IL-2Ra	NULL
TCCA	NULL
GGGG	NULL
AATC	NULL
TC	NULL
+	NULL
HIV-LTR	NULL
(	NULL
3	NULL
'	NULL
)	NULL
TCT	NULL
sees	NULL
AcTT	NULL
TC	NULL
+	NULL
NF-	NULL
«	NULL
B	NULL
CONSENSUS	NULL
GGGR	NULL
NNYY	NULL
CC	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6000	NULL
A	NULL
-	NULL
#	NULL
a	NULL
-	NULL
©	NULL
a	NULL
-	NULL
a	NULL
©	NULL
a	NULL
®	NULL
a	NULL
``	NULL
®	NULL
t	NULL
``	NULL
©	NULL
®	NULL
``	NULL
m	NULL
``	NULL
$	NULL
®	NULL
so	NULL
§	NULL
5	NULL
po	NULL
§	NULL
po	NULL
9	NULL
p	NULL
€	NULL
€	NULL
T	NULL
2	NULL
7	NULL
T	NULL
<	NULL
T	NULL
=	NULL
T	NULL
1	NULL
d	NULL
s	NULL
8	NULL
i	NULL
@	NULL
g	NULL
8	NULL
U	NULL
&	NULL
8	NULL
U	NULL
ca	NULL
8	NULL
J	NULL
I	NULL
1	NULL
bog	NULL
bss	NULL
|	NULL
i	NULL
§	NULL
#	NULL
#	NULL
i	NULL
RAMOS+	NULL
RAMOS+	NULL
_	NULL
RAMOS+	NULL
-	NULL
RAMOS+	NULL
anti-CD40	NULL
Mab	NULL
__	NULL
TNF-a	NULL
IFN-y	NULL
IL-4	NULL
®	NULL
1	NULL
o	NULL
®	NULL
a	NULL
n	NULL
n	NULL
B	NULL
t	NULL
E	NULL
CJ	NULL
E	NULL
c	NULL
%	NULL
C	NULL
$	NULL
4	NULL
po	NULL
$	NULL
p	NULL
5	NULL
p	NULL
=	NULL
-	NULL
E	NULL
=	NULL
E	NULL
=	NULL
€	NULL
5	NULL
5	NULL
8	NULL
§	NULL
8	NULL
.	NULL

5	NULL
8	NULL
RAMOS+	NULL
HepG2+	NULL
FDtrk	NULL
+	NULL
anti-CD40	NULL
Mab	NULL
IL-6	NULL
IL-3	NULL
C	NULL
ISG-15	NULL
IRF-1	NULL
ISRE	NULL
GAS	NULL
N	NULL
a	NULL
N	NULL
a	NULL
m	NULL
``	NULL
®	NULL
m	NULL
®	NULL
®	NULL
po	NULL
§	NULL
p	NULL
=	NULL
T	NULL
=	NULL
T	NULL
COMP	NULL
.	NULL

_	NULL
.	NULL

&	NULL
8	NULL
.	NULL

§	NULL
8	NULL
ISGF3	NULL
l	NULL
CD40	NULL
inducible	NULL
H	NULL
complex	NULL
,	NULL
088	NULL
<	NULL
RAMOS+	NULL
_	NULL
RAMOS+	NULL
IFN-	NULL
__	NULL
anti-CD40	NULL
Mab	NULL
FIGURE	NULL
3	NULL
.	NULL

Comparison	NULL
of	NULL
IRF-1	NULL
GAS-binding	NULL
activities	NULL
induced	NULL
by	NULL
CD40	NULL
,	NULL
TNF-a	NULL
,	NULL
IFN-y	NULL
,	NULL
or	NULL
IL-4	NULL
stimulation	NULL
by	NULL
STAT	NULL
antisera	NULL
reactivity	NULL
.	NULL

A	NULL
,	NULL
Ramos	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
anti-CD40	NULL
mAb	NULL
,	NULL
human	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/m1	NULL
)	NULL
,	NULL
human	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
or	NULL
human	NULL
IL-4	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
examined	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Ab	NULL
interference	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
conducted	NULL
by	NULL
addition	NULL
of	NULL
either	NULL
an	NULL
antiserum	NULL
against	NULL
Statl	NULL
or	NULL
against	NULL
Stat6	NULL
or	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
control	NULL
)	NULL
.	NULL

All	NULL
antisera	NULL
were	NULL
added	NULL
at	NULL
a	NULL
final	NULL
dilution	NULL
of	NULL
1:20	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
before	NULL
incubation	NULL
with	NULL
the	NULL
IRF-1	NULL
GAS	NULL
probe	NULL
for	NULL
20	NULL
min	NULL
at	NULL
25°C	NULL
.	NULL

B	NULL
,	NULL
Ramos	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CDAO0	NULL
mAb	NULL
.	NULL

Extracts	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
examined	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Ab	NULL
interference	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
conducted	NULL
as	NULL
above	NULL
by	NULL
addition	NULL
of	NULL
either	NULL
an	NULL
antiserum	NULL
against	NULL
Stat3	NULL
or	NULL
Stats	NULL
or	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
control	NULL
)	NULL
.	NULL

IL-6-treated	NULL
HepG2	NULL
extracts	NULL
and	NULL
IL-3-treated	NULL
FDirk	NULL
extracts	NULL
known	NULL
to	NULL
contain	NULL
Stat3	NULL
and	NULL
Stat5	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr.	NULL
Chris	NULL
Schindler	NULL
.	NULL

C	NULL
,	NULL
Ramos	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
anti-CD40	NULL
mAb	NULL
or	NULL
human	NULL
IFN-	NULL
«	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
assayed	NULL
with	NULL
either	NULL
an	NULL
ISG-15	NULL
interferon-stimulated	NULL
response	NULL
element	NULL
probe	NULL
(	NULL
to	NULL
detect	NULL
the	NULL
Stat2	NULL
containing	NULL
ISGF3	NULL
com-plex	NULL
)	NULL
or	NULL
the	NULL
IRF-1	NULL
GAS	NULL
probe	NULL
.	NULL

Ab	NULL
interference	NULL
assays	NULL
were	NULL
conducted	NULL
as	NULL
above	NULL
by	NULL
addition	NULL
of	NULL
either	NULL
an	NULL
antiserum	NULL
against	NULL
Stat2	NULL
or	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
control	NULL
)	NULL
.	NULL

appearance	NULL
of	NULL
the	NULL
IFN-y-inducible	NULL
Statl	NULL
homodimer	NULL
.	NULL

Thus	NULL
,	NULL
binding	NULL
of	NULL
the	NULL
CD4O0-inducible	NULL
complex	NULL
can	NULL
be	NULL
mediated	NULL
only	NULL
by	NULL
a	NULL
restricted	NULL
subset	NULL
of	NULL
GAS-containing	NULL
DNA	NULL
regions	NULL
.	NULL

CONVERGENCE	NULL
OF	NULL
SIGNALS	NULL
BY	NULL
TNF-	NULL
AND	NULL
CYTOKINE-RECEPTOR	NULL
FAMILIES	NULL
a	NULL
a	NULL
©	NULL
T	NULL
¥	NULL
¥	NULL
U	NULL
,	NULL
U	NULL
c	NULL
&	NULL
®	NULL
$	NULL
t	NULL
$	NULL
o	NULL
$	NULL
o	NULL
&	NULL
9	NULL
i	NULL
u	NULL
u	NULL
,	NULL
x	NULL
x	NULL
&	NULL
ZI	NULL
-	NULL
£	NULL
Z	NULL
&	NULL
7	NULL
«	NULL
o	NULL
>	NULL
Log	NULL
-o	NULL
4	NULL
>	NULL
COMP	NULL
.	NULL

1o=	NULL
<	NULL
I	NULL
5	NULL
.	NULL

=	NULL
P	NULL
a	NULL
=	NULL
I	NULL
F	NULL
RAMOS	NULL
+	NULL
RAMOS+	NULL
-	NULL
RAMOS+	NULL
CD40L	NULL
tx	NULL
IFN-y	NULL
IL-4	NULL
FIGURE	NULL
4	NULL
.	NULL

Comparison	NULL
of	NULL
IRF-1	NULL
GAS-binding	NULL
activities	NULL
induced	NULL
by	NULL
CD40	NULL
,	NULL
IFN-y	NULL
,	NULL
or	NULL
IL-4	NULL
stimulation	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
competition	NULL
.	NULL

Ramos	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
CD4OL	NULL
tx	NULL
,	NULL
human	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
human	NULL
IL-4	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
examined	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Oligonucleotide	NULL
competition	NULL
assays	NULL
were	NULL
performed	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
NF-KB	NULL
oligonucleotides	NULL
added	NULL
to	NULL
the	NULL
shift	NULL
reaction	NULL
as	NULL
indicated	NULL
.	NULL

Competitors	NULL
included	NULL
IL-2Ra	NULL
«	NULL
NF-KB	NULL
,	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
IRE-1	NULL
GAS	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
absence	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
the	NULL
CD4O0-	NULL
and	NULL
TNF-	NULL
«	NULL
-inducible	NULL
complex	NULL
,	NULL
we	NULL
analyzed	NULL
these	NULL
complexes	NULL
by	NULL
supershift	NULL
experiments	NULL
with	NULL
a	NULL
panel	NULL
of	NULL
antisera	NULL
against	NULL
STAT	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
against	NULL
Stat2	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
the	NULL
Ab	NULL
supershifted	NULL
complexes	NULL
known	NULL
to	NULL
contain	NULL
specific	NULL
STAT	NULL
's	NULL
,	NULL
but	NULL
none	NULL
of	NULL
the	NULL
antisera	NULL
affected	NULL
the	NULL
€CD4O0-	NULL
or	NULL
the	NULL
TNF-	NULL
&	NULL
-inducible	NULL
complex	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
different	NULL
STAT	NULL
antisera	NULL
were	NULL
utilized	NULL
to	NULL
supershift	NULL
the	NULL
constitutive	NULL
complex	NULL
detected	NULL
in	NULL
EBV-transformed	NULL
B	NULL
cells	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Other	NULL
groups	NULL
have	NULL
employed	NULL
immunoprecipitation	NULL
assays	NULL
to	NULL
detect	NULL
the	NULL
activation	NULL
of	NULL
Stat3	NULL
and	NULL
Stat6	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
lack	NULL
of	NULL
STAT	NULL
activation	NULL
in	NULL
our	NULL
system	NULL
,	NULL
we	NULL
thus	NULL
performed	NULL
immunoprecipitations	NULL
with	NULL
either	NULL
a	NULL
Stat6	NULL
or	NULL
a	NULL
Stat3	NULL
antiserum	NULL
on	NULL
extracts	NULL
from	NULL
CD4O-stimulated	NULL
Ramos	NULL
cells	NULL
.	NULL

Despite	NULL
adequate	NULL
STAT	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
appropriate	NULL
cytokine	NULL
stimulation	NULL
,	NULL
we	NULL
failed	NULL
to	NULL
detect	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
either	NULL
Stat3	NULL
or	NULL
Stat6	NULL
upon	NULL
CD40	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
Stat6	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
was	NULL
also	NULL
confirmed	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
extracts	NULL
from	NULL
a	NULL
different	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
BL-41	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
,	NULL
thus	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
complex	NULL
we	NULL
detect	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
EBV	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
non-STAT	NULL
proteins	NULL
.	NULL

The	NULL
CD4O-inducible	NULL
complex	NULL
binding	NULL
to	NULL
the	NULL
IRF-1	NULL
GAS	NULL
contains	NULL
NF-	NULL
«	NULL
B-related	NULL
proteins	NULL
The	NULL
rapid	NULL
induction	NULL
of	NULL
the	NULL
CD4O-inducible	NULL
complex	NULL
as	NULL
well	NULL
as	NULL
its	NULL
resistance	NULL
to	NULL
cycloheximide	NULL
treatment	NULL
suggested	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
latent	NULL
cytoplasmic	NULL
factor	NULL
within	NULL
the	NULL
complex	NULL
.	NULL

Given	NULL
the	NULL
known	NULL
ability	NULL
of	NULL
CD40	NULL
cross-linking	NULL
to	NULL
activate	NULL
NF-KB	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
the	NULL
partial	NULL
overlap	NULL
of	NULL
the	NULL
IRF-1	NULL
GAS	NULL
element	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
site	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
,	NULL
we	NULL
entertained	NULL
the	NULL
idea	NULL
that	NULL
this	NULL
inducible	NULL
complex	NULL
might	NULL
indeed	NULL
be	NULL
composed	NULL
of	NULL
Rel	NULL
family	NULL
members	NULL
.	NULL

Oligonucleotide	NULL
competitions	NULL
revealed	NULL
that	NULL
known	NULL
NF-KB	NULL
sites	NULL
(	NULL
15	NULL
)	NULL
were	NULL
able	NULL
to	NULL
effectively	NULL
compete	NULL
for	NULL
this	NULL
CD4O0-inducible	NULL
complex	NULL
but	NULL
not	NULL
for	NULL
the	NULL
known	NULL
STAT	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Ab	NULL
supershifting	NULL
experiments	NULL
with	NULL
a	NULL
panel	NULL
of	NULL
commercially	NULL
available	NULL
Rel	NULL
antisera	NULL
confirmed	NULL
this	NULL
finding	NULL
and	NULL
demonstrated	NULL
that	NULL
the	NULL
CD4O0-inducible	NULL
complex	NULL
contains	NULL
both	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
or	NULL
antigenically	NULL
related	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neither	NULL
the	NULL
IL-4-	NULL
nor	NULL
the	NULL
IFN-y-inducible	NULL
complexes	NULL
were	NULL
affected	NULL
by	NULL
these	NULL
antisera	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
binding	NULL
to	NULL
the	NULL
IRF-1	NULL
GAS	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
antisera	NULL
recognizing	NULL
p52	NULL
or	NULL
RelB	NULL
and	NULL
only	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
a	NULL
a	NULL
_	NULL
o	NULL
m	NULL
m	NULL
``	NULL
o	NULL
m	NULL
G	NULL
``	NULL
o	NULL
u	NULL
%	NULL
w	NULL
@	NULL
n	NULL
_	NULL
wm	NULL
©	NULL
o_	NULL
n	NULL
©	NULL
+	NULL
a	NULL
a	NULL
9	NULL
5	NULL
a	NULL
o	NULL
8	NULL
%	NULL
a	NULL
a	NULL
0	NULL
&	NULL
uk	NULL
A	NULL
E	NULL
Loun	NULL
l	NULL
B	NULL
E	NULL
w	NULL
m	NULL
&	NULL
a	NULL
Lo-	NULL
E	NULL
-	NULL
-	NULL
-	NULL
C	NULL
_	NULL
Bow	NULL
c	NULL
€	NULL
C	NULL
C	NULL
-	NULL
€	NULL
€	NULL
&	NULL
[	NULL
=	NULL
COMP	NULL
.	NULL

1-5	NULL
5	NULL
&	NULL
8	NULL
5	NULL
5	NULL
&	NULL
8	NULL
a	NULL
a	NULL
a	NULL
RAMOS+	NULL
JY	NULL
CD4O0L	NULL
tx	NULL
TNF	NULL
a	NULL
FIGURE	NULL
5	NULL
.	NULL

The	NULL
CD4O-inducible	NULL
IRF-1	NULL
GAS-binding	NULL
complex	NULL
contains	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

Ramos	NULL
cells	NULL
were	NULL
stimulated	NULL
and	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

JY	NULL
cells	NULL
were	NULL
unstimulated	NULL
.	NULL

Ab	NULL
interference	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
conducted	NULL
by	NULL
addition	NULL
of	NULL
either	NULL
an	NULL
antiserum	NULL
against	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
or	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
control	NULL
)	NULL
.	NULL

Antisera	NULL
were	NULL
added	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

3.	NULL
minimally	NULL
by	NULL
antisera	NULL
recognizing	NULL
two	NULL
distinct	NULL
c-Rel	NULL
epitopes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
identical	NULL
pattern	NULL
of	NULL
competition	NULL
was	NULL
also	NULL
displayed	NULL
by	NULL
both	NULL
the	NULL
TNF-	NULL
«	NULL
@	NULL
-inducible	NULL
complex	NULL
and	NULL
the	NULL
constitutive	NULL
complex	NULL
detected	NULL
in	NULL
EBV-transformed	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
results	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
CD4O0-inducible	NULL
complex	NULL
was	NULL
prevented	NULL
by	NULL
pretreatment	NULL
with	NULL
TPCK	NULL
,	NULL
a	NULL
proteasome	NULL
inhibitor	NULL
known	NULL
to	NULL
block	NULL
degradation	NULL
of	NULL
IxB-	NULL
«	NULL
and	NULL
thus	NULL
p50/p65	NULL
translocation	NULL
and	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
p65	NULL
binding	NULL
to	NULL
the	NULL
IRF-1	NULL
promoter	NULL
in	NULL
both	NULL
CD40L-treated	NULL
Ramos	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
an	NULL
EBV-transformed	NULL
B	NULL
cell	NULL
line	NULL
(	NULL
JY	NULL
)	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
subjecting	NULL
these	NULL
DNA-binding	NULL
complexes	NULL
to	NULL
UV	NULL
cross-linking	NULL
followed	NULL
by	NULL
immunoprecipitations	NULL
with	NULL
a	NULL
p65	NULL
antiserum	NULL
(	NULL
See	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Re	NULL
E	NULL
x	NULL
©	NULL
a	NULL
=	NULL
%	NULL
sei	NULL
E	NULL
+	NULL
c	NULL
;	NULL
+	NULL
+	NULL
HHE	NULL
Cc	NULL
C	NULL
5	NULL
-116	NULL
Stat	NULL
3	NULL
-	NULL
»	NULL
-84	NULL
§	NULL
-e	NULL
|	NULL
«	NULL
«	NULL
®	NULL
wo	NULL
689	NULL
g	NULL
-58	NULL
i	NULL
®	NULL
-48	NULL
IP	NULL
:	NULL
anti-	NULL
anti-p65	NULL
Stat	NULL
3	NULL
Probe	NULL
:	NULL
_	NULL
[	NULL
*2PJBUdR-IRF1	NULL
GAS	NULL
;	NULL
.	NULL

Probe	NULL
:	NULL
anti-p65	NULL
FIGURE	NULL
6	NULL
.	NULL

Induction	NULL
of	NULL
p65	NULL
binding	NULL
to	NULL
the	NULL
IRF-1	NULL
GAS	NULL
is	NULL
detected	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
stimulation	NULL
in	NULL
Ramos	NULL
cells	NULL
or	NULL
constitutively	NULL
in	NULL
an	NULL
EBV-transformed	NULL
B	NULL
cell	NULL
line	NULL
(	NULL
JY	NULL
)	NULL
by	NULL
UV	NULL
cross-linking	NULL
followed	NULL
by	NULL
p65	NULL
immu-noprecipitation	NULL
.	NULL

Ramos	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
CD4O0L	NULL
tx	NULL
,	NULL
control	NULL
tx	NULL
,	NULL
or	NULL
human	NULL
IFN-a	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

JY	NULL
cells	NULL
were	NULL
unstimulated	NULL
.	NULL

Extracts	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
radiolabeled	NULL
5-bro-modeoxyuridine	NULL
substituted	NULL
IRF-1	NULL
GAS	NULL
probe	NULL
(	NULL
BUdR-IRF-1	NULL
GAS	NULL
)	NULL
in	NULL
a	NULL
standard	NULL
shift	NULL
reaction	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
then	NULL
irradiated	NULL
twice	NULL
with	NULL
1000	NULL
mJ	NULL
of	NULL
UV	NULL
and	NULL
then	NULL
immunoprecipitated	NULL
with	NULL
either	NULL
a	NULL
p65	NULL
or	NULL
a	NULL
Stat3	NULL
antiserum	NULL
as	NULL
control	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
resolved	NULL
by	NULL
7	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
an	NULL
x-ray	NULL
film	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
later	NULL
stripped	NULL
and	NULL
probed	NULL
with	NULL
a	NULL
p65	NULL
antiserum	NULL
to	NULL
insure	NULL
equal	NULL
loading	NULL
of	NULL
precipitates	NULL
.	NULL

No	NULL
cross-linking	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
UV	NULL
irradiation	NULL
.	NULL

6001	NULL
A	NULL
x	NULL
“	NULL
g	NULL
<	NULL
¢	NULL
-f	NULL
£	NULL
%	NULL
+/+	NULL
x	NULL
x	NULL
x	NULL
``	NULL
8	NULL
&	NULL
I	NULL
$	NULL
4	NULL
4	NULL
&	NULL
4	NULL
f	NULL
f	NULL
f	NULL
i	NULL
_	NULL
<	NULL
&	NULL
o	NULL
o	NULL
o	NULL
8	NULL
8	NULL
8	NULL
5	NULL
?	NULL

p	NULL
f	NULL
©	NULL
«	NULL
©	NULL
B	NULL
%	NULL
_	NULL
®	NULL
_	NULL
#	NULL
o	NULL
®	NULL
o	NULL
=	NULL
€	NULL
=o	NULL
€	NULL
comp	NULL
.	NULL

.	NULL

§	NULL
8	NULL
.	NULL

§	NULL
8	NULL
L	NULL
...	NULL
wr-	NULL
‘	NULL
D	NULL
'	NULL
RAMDS+	NULL
RAMOS+	NULL
IL-4	NULL
_	NULL
CD40L	NULL
tx	NULL
+	NULL
IL-4	NULL
FIGURE	NULL
7	NULL
.	NULL

Simultaneous	NULL
activation	NULL
of	NULL
Ramos	NULL
cells	NULL
with	NULL
CD4OL	NULL
and	NULL
IL-4	NULL
or	NULL
CD40L	NULL
and	NULL
IFN-y	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
STAT/Re	NULL
!	NULL

l	NULL
complex	NULL
.	NULL

A	NULL
,	NULL
Cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
CD4O0L	NULL
tx	NULL
,	NULL
control	NULL
tx	NULL
,	NULL
human	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
human	NULL
IL-4	NULL
(	NULL
100	NULL
U/ml	NULL
!	NULL
)	NULL

either	NULL
alone	NULL
or	NULL
in	NULL
combina-tion	NULL
.	NULL

Extracts	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

B	NULL
,	NULL
Ab	NULL
interference	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
conducted	NULL
by	NULL
addition	NULL
of	NULL
either	NULL
an	NULL
antiserum	NULL
against	NULL
Staté	NULL
or	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
control	NULL
)	NULL
.	NULL

Antisera	NULL
were	NULL
added	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

3.	NULL
probing	NULL
of	NULL
the	NULL
filter	NULL
with	NULL
a	NULL
p65	NULL
antiserum	NULL
ensured	NULL
for	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
immunoprecipitates	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
studies	NULL
indicate	NULL
that	NULL
,	NULL
at	NULL
the	NULL
IRF-1	NULL
promoter	NULL
,	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
CD40	NULL
stimulation	NULL
converges	NULL
on	NULL
the	NULL
same	NULL
regulatory	NULL
region	NULL
targeted	NULL
by	NULL
cytokine	NULL
signals	NULL
.	NULL

Simultaneous	NULL
treatment	NULL
of	NULL
B	NULL
cells	NULL
with	NULL
CD40	NULL
and	NULL
cytokines	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
novel	NULL
complexes	NULL
at	NULL
the	NULL
IRF-1	NULL
promoter	NULL
Given	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
IRF-1	NULL
GAS	NULL
to	NULL
function	NULL
as	NULL
a	NULL
common	NULL
binding	NULL
site	NULL
for	NULL
distinct	NULL
transcription	NULL
factors	NULL
,	NULL
we	NULL
evaluated	NULL
whether	NULL
simultaneous	NULL
treatment	NULL
with	NULL
CD4O0L	NULL
and	NULL
cytokines	NULL
would	NULL
lead	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
novel	NULL
complex	NULL
between	NULL
STAT	NULL
's	NULL
and	NULL
Rel	NULL
proteins	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
exposure	NULL
of	NULL
Ramos	NULL
cells	NULL
to	NULL
CD4OL	NULL
transfectants	NULL
together	NULL
with	NULL
either	NULL
IL-4	NULL
or	NULL
IFN-y	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
an	NULL
additional	NULL
STAT/Rel	NULL
complex	NULL
or	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
individual	NULL
complexes	NULL
.	NULL

Moreover	NULL
,	NULL
supershifting	NULL
experiments	NULL
with	NULL
a	NULL
Stat6é	NULL
Ab	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
demonstrated	NULL
that	NULL
only	NULL
the	NULL
IL-4-inducible	NULL
complex	NULL
contains	NULL
Stat6	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
,	NULL
at	NULL
the	NULL
IRF-1	NULL
GAS	NULL
,	NULL
STAT	NULL
and	NULL
Rel	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
maintained	NULL
as	NULL
separate	NULL
entities	NULL
.	NULL

Alternatively	NULL
,	NULL
these	NULL
two	NULL
distinct	NULL
classes	NULL
of	NULL
transcription	NULL
factors	NULL
may	NULL
bind	NULL
this	NULL
DNA	NULL
element	NULL
as	NULL
alternate	NULL
complexes	NULL
.	NULL

Functional	NULL
consequences	NULL
of	NULL
NF-kB	NULL
binding	NULL
to	NULL
the	NULL
IRF-1	NULL
GAS	NULL
To	NULL
determine	NULL
whether	NULL
CD40	NULL
stimulation	NULL
could	NULL
lead	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
IREF-1	NULL
in	NULL
our	NULL
system	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
RNA	NULL
obtained	NULL
from	NULL
Ramos	NULL
cells	NULL
after	NULL
stimulation	NULL
for	NULL
different	NULL
lengths	NULL
of	NULL
time	NULL
with	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
IRF-1	NULL
TIME	NULL
:	NULL
45	NULL
'	NULL
2h	NULL
45°	NULL
2h	NULL
45	NULL
'	NULL
2h	NULL
2h	NULL
45	NULL
2h	NULL
TX	NULL
-	NULL
-	NULL
control	NULL
CO40L	NULL
TNF-a	NULL
IFN-	NULL
IFN-y	NULL
tx	NULL
tx	NULL
B	NULL
control	NULL
tx	NULL
CD40L	NULL
tx	NULL
(	NULL
s	NULL
IFN-y	NULL
Wl	NULL
~	NULL
_	NULL
_	NULL
``	NULL
FIGURE	NULL
8	NULL
.	NULL

Induction	NULL
of	NULL
IRF-1	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
or	NULL
TNF-a	NULL
stimulation	NULL
in	NULL
Ramos	NULL
but	NULL
not	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Ramos	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
CD4O0L	NULL
tx	NULL
,	NULL
control	NULL
tx	NULL
,	NULL
human	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
human	NULL
IFN-a	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
,	NULL
or	NULL
human	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
either	NULL
45	NULL
min	NULL
or	NULL
2	NULL
h.	NULL
Total	NULL
RNA	NULL
was	NULL
then	NULL
extracted	NULL
,	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
the	NULL
RNA	NULL
was	NULL
assayed	NULL
by	NULL
Northern	NULL
blotting	NULL
as	NULL
per	NULL
standard	NULL
protocols	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
then	NULL
probed	NULL
with	NULL
either	NULL
an	NULL
IRF-1	NULL
cDNA	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
GAPDH	NULL
cDNA	NULL
radiolabeled	NULL
by	NULL
random	NULL
hexamer	NULL
priming	NULL
.	NULL

B	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
CD4O0L	NULL
tx	NULL
,	NULL
control	NULL
tx	NULL
,	NULL
human	NULL
IFN-	NULL
(	NULL
100	NULL
U/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
or	NULL
human	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
45	NULL
min	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
then	NULL
extracted	NULL
and	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
A.	NULL
CD40L	NULL
tx	NULL
,	NULL
control	NULL
tx	NULL
,	NULL
or	NULL
TNF-a	NULL
.	NULL

Northern	NULL
analysis	NULL
of	NULL
these	NULL
samples	NULL
revealed	NULL
that	NULL
stimulation	NULL
of	NULL
Ramos	NULL
cells	NULL
for	NULL
45	NULL
min	NULL
with	NULL
CD40L	NULL
or	NULL
TNF-a	NULL
led	NULL
,	NULL
respectively	NULL
,	NULL
to	NULL
a	NULL
fivefold	NULL
and	NULL
threefold	NULL
induction	NULL
of	NULL
IRF-1	NULL
expression	NULL
as	NULL
measured	NULL
by	NULL
densitometry	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

This	NULL
induction	NULL
was	NULL
short-lived	NULL
because	NULL
it	NULL
had	NULL
diminished	NULL
by	NULL
2	NULL
h	NULL
and	NULL
was	NULL
undetectable	NULL
at	NULL
24	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Exposure	NULL
to	NULL
IFN-y	NULL
led	NULL
to	NULL
a	NULL
stronger	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
that	NULL
lasted	NULL
up	NULL
to	NULL
24	NULL
h.	NULL
In	NULL
contrast	NULL
,	NULL
CD40	NULL
stimulation	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
IRF-1	NULL
up-regulation	NULL
in	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
,	NULL
despite	NULL
activating	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
by	NULL
EMSA	NULL
and	NULL
despite	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
cell	NULL
line	NULL
to	NULL
up-regulate	NULL
IRF-1	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
CD40	NULL
and	NULL
cytokine	NULL
signals	NULL
converge	NULL
on	NULL
similar	NULL
target	NULL
genes	NULL
,	NULL
utilization	NULL
of	NULL
distinct	NULL
components	NULL
by	NULL
each	NULL
cascade	NULL
allows	NULL
for	NULL
varying	NULL
levels	NULL
of	NULL
responsiveness	NULL
.	NULL

Moreover	NULL
,	NULL
cell	NULL
type-specific	NULL
constraints	NULL
may	NULL
modulate	NULL
whether	NULL
a	NULL
response	NULL
will	NULL
take	NULL
place	NULL
.	NULL

Discussion	NULL
Our	NULL
studies	NULL
demonstrate	NULL
that	NULL
incoming	NULL
signals	NULL
provided	NULL
by	NULL
stimulation	NULL
of	NULL
B	NULL
cells	NULL
by	NULL
the	NULL
TNF-	NULL
or	NULL
the	NULL
cytokine-receptor	NULL
families	NULL
target	NULL
the	NULL
GAS	NULL
element	NULL
of	NULL
the	NULL
IRF-1	NULL
promoter	NULL
.	NULL

In	NULL
our	NULL
experimental	NULL
system	NULL
,	NULL
distinct	NULL
classes	NULL
of	NULL
transcription	NULL
factors	NULL
are	NULL
utilized	NULL
by	NULL
the	NULL
different	NULL
receptor	NULL
families	NULL
,	NULL
Rel	NULL
proteins	NULL
in	NULL
the	NULL
case	NULL
of	NULL
CD40	NULL
,	NULL
EBV	NULL
,	NULL
or	NULL
TNF-a	NULL
and	NULL
STAT	NULL
's	NULL
in	NULL
the	NULL
case	NULL
of	NULL
cytokines	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
point	NULL
out	NULL
that	NULL
among	NULL
other	NULL
GAS	NULL
elements	NULL
tested	NULL
only	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
CD23b	NULL
GAS	NULL
appears	NULL
to	NULL
function	NULL
as	NULL
a	NULL
composite	NULL
NF-	NULL
«	NULL
B/STAT	NULL
binding	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
DNA	NULL
elements	NULL
encompassing	NULL
the	NULL
IRF-1	NULL
and	NULL
CD23b	NULL
GAS	NULL
differ	NULL
in	NULL
the	NULL
location	NULL
of	NULL
potential	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
subtle	NULL
differences	NULL
in	NULL
CONVERGENCE	NULL
OF	NULL
SIGNALS	NULL
BY	NULL
TNF-	NULL
AND	NULL
CYTOKINE-RECEPTOR	NULL
FAMILIES	NULL
the	NULL
interaction	NULL
between	NULL
NF-KB	NULL
and	NULL
STAT	NULL
complexes	NULL
at	NULL
these	NULL
GAS	NULL
elements	NULL
may	NULL
,	NULL
however	NULL
,	NULL
exist	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
differential	NULL
ability	NULL
of	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
CD23a	NULL
and	NULL
CD23b	NULL
GAS	NULL
to	NULL
mediate	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
correlates	NULL
with	NULL
a	NULL
differential	NULL
regulation	NULL
of	NULL
the	NULL
two	NULL
CD23	NULL
isoforms	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
and/or	NULL
IL-4	NULL
(	NULL
our	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
GAS	NULL
element	NULL
to	NULL
mediate	NULL
binding	NULL
of	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
STATs	NULL
may	NULL
reflect	NULL
specific	NULL
regulatory	NULL
requirements	NULL
.	NULL

The	NULL
simultaneous	NULL
targeting	NULL
of	NULL
the	NULL
IRF-1	NULL
GAS	NULL
by	NULL
Rel	NULL
and	NULL
STAT	NULL
proteins	NULL
suggests	NULL
that	NULL
regulation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
IRF-1	NULL
may	NULL
represent	NULL
a	NULL
critical	NULL
control	NULL
point	NULL
in	NULL
the	NULL
progression	NULL
of	NULL
B	NULL
cells	NULL
toward	NULL
proliferation	NULL
and/or	NULL
other	NULL
differentiative	NULL
pathways	NULL
.	NULL

Although	NULL
only	NULL
a	NULL
modest	NULL
induction	NULL
of	NULL
IRF-1	NULL
is	NULL
detected	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
small	NULL
changes	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
transactivators	NULL
may	NULL
be	NULL
translated	NULL
into	NULL
transcriptional	NULL
synergy	NULL
because	NULL
of	NULL
cooperative	NULL
interactions	NULL
within	NULL
multiprotein	NULL
enhancer	NULL
complexes	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
activation	NULL
of	NULL
both	NULL
NF-KB	NULL
and	NULL
IRF-1	NULL
by	NULL
CD40	NULL
may	NULL
lead	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
transcriptional	NULL
complex	NULL
that	NULL
then	NULL
may	NULL
target	NULL
additional	NULL
CD4O-responsive	NULL
genes	NULL
.	NULL

It	NULL
must	NULL
also	NULL
be	NULL
pointed	NULL
out	NULL
that	NULL
IRF-1	NULL
can	NULL
mediate	NULL
growth	NULL
inhibition	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
overexpression	NULL
of	NULL
IRF-1	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
deleterious	NULL
to	NULL
B	NULL
cell	NULL
development	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
modest	NULL
induction	NULL
of	NULL
IRF-1	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
may	NULL
allow	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
additional	NULL
target	NULL
genes	NULL
without	NULL
endangering	NULL
the	NULL
proliferative	NULL
capability	NULL
of	NULL
B	NULL
cells	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
is	NULL
followed	NULL
by	NULL
a	NULL
much	NULL
stronger	NULL
induction	NULL
of	NULL
the	NULL
recently	NULL
cloned	NULL
IRF-4	NULL
(	NULL
also	NULL
termed	NULL
ICSAT	NULL
,	NULL
Pip	NULL
,	NULL
LSIRF	NULL
,	NULL
or	NULL
MUMI1	NULL
(	NULL
47-50	NULL
)	NULL
)	NULL
(	NULL
S.	NULL
Gupta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
manuscript	NULL
in	NULL
prep-aration	NULL
)	NULL
.	NULL

IRF-4	NULL
is	NULL
likely	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
B	NULL
cell	NULL
biology	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
IRF-4	NULL
ko	NULL
mice	NULL
display	NULL
significant	NULL
defects	NULL
in	NULL
mature	NULL
B	NULL
cell	NULL
functions	NULL
(	NULL
51	NULL
)	NULL
.	NULL

An	NULL
investigation	NULL
of	NULL
the	NULL
IRF-4	NULL
promoter	NULL
has	NULL
revealed	NULL
potential	NULL
NF-	NULL
«	NULL
B-	NULL
and	NULL
IRF-1-binding	NULL
se-quences	NULL
.	NULL

Interestingly	NULL
,	NULL
CD40	NULL
stimulation	NULL
of	NULL
THP-1	NULL
cells	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
but	NULL
not	NULL
of	NULL
IRF-1	NULL
,	NULL
is	NULL
not	NULL
accompanied	NULL
by	NULL
the	NULL
up-regulation	NULL
of	NULL
IRF-4	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
similar	NULL
IRF-1	NULL
GAS-binding	NULL
complexes	NULL
are	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
EBV	NULL
stimulation	NULL
is	NULL
further	NULL
evidence	NULL
that	NULL
the	NULL
biologic	NULL
overlap	NULL
demonstrated	NULL
by	NULL
these	NULL
stimuli	NULL
on	NULL
B	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
52	NULL
,	NULL
53	NULL
)	NULL
is	NULL
reflected	NULL
in	NULL
the	NULL
common	NULL
usage	NULL
of	NULL
a	NULL
similar	NULL
set	NULL
of	NULL
signaling	NULL
mechanisms	NULL
.	NULL

Given	NULL
the	NULL
ability	NULL
of	NULL
IRF-1	NULL
to	NULL
act	NULL
as	NULL
a	NULL
tumor	NULL
suppressor	NULL
gene	NULL
and	NULL
inhibit	NULL
cell	NULL
growth	NULL
(	NULL
25	NULL
)	NULL
,	NULL
modulation	NULL
of	NULL
IRF-1	NULL
levels	NULL
by	NULL
EBV	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
viral	NULL
immortalization	NULL
process	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
because	NULL
IRFs	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
complex	NULL
transcriptional	NULL
regulation	NULL
of	NULL
EBNA-1	NULL
(	NULL
54-56	NULL
)	NULL
,	NULL
a	NULL
viral	NULL
protein	NULL
critical	NULL
for	NULL
maintenance	NULL
of	NULL
EBV	NULL
latency	NULL
(	NULL
53	NULL
)	NULL
,	NULL
the	NULL
targeting	NULL
of	NULL
IRF-1	NULL
by	NULL
EBV	NULL
may	NULL
reflect	NULL
the	NULL
virus	NULL
's	NULL
own	NULL
need	NULL
to	NULL
carefully	NULL
control	NULL
the	NULL
balance	NULL
of	NULL
distinct	NULL
IRFs	NULL
within	NULL
a	NULL
B	NULL
cell	NULL
.	NULL

CD40	NULL
stimulation	NULL
has	NULL
been	NULL
previously	NULL
reported	NULL
to	NULL
activate	NULL
Rel-containing	NULL
complexes	NULL
in	NULL
both	NULL
human	NULL
and	NULL
murine	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
11	NULL
,	NULL
57	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
complexes	NULL
differ	NULL
from	NULL
the	NULL
one	NULL
detected	NULL
at	NULL
the	NULL
IRF-1	NULL
GAS	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
pattern	NULL
of	NULL
bands	NULL
as	NULL
well	NULL
as	NULL
Rel	NULL
antisera	NULL
competitions	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
particular	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
IRF-1	NULL
GAS	NULL
allows	NULL
for	NULL
the	NULL
differential	NULL
recognition	NULL
of	NULL
this	NULL
site	NULL
by	NULL
a	NULL
specific	NULL
Rel	NULL
complex	NULL
.	NULL

Because	NULL
the	NULL
expression	NULL
of	NULL
Rel	NULL
complexes	NULL
changes	NULL
with	NULL
terminal	NULL
B	NULL
cell	NULL
differentiation	NULL
(	NULL
58-60	NULL
)	NULL
,	NULL
the	NULL
precise	NULL
maturation	NULL
stage	NULL
of	NULL
a	NULL
B	NULL
cell	NULL
might	NULL
modulate	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
CD40	NULL
signaling	NULL
pathway	NULL
to	NULL
target	NULL
this	NULL
gene	NULL
.	NULL

Preliminary	NULL
studies	NULL
with	NULL
purified	NULL
recombinant	NULL
p50	NULL
and	NULL
p65	NULL
have	NULL
confirmed	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
proteins	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
element	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
additional	NULL
factors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
IRF-1	NULL
by	NULL
CD40	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
complex	NULL
.	NULL

Indeed	NULL
,	NULL
CD40	NULL
stimulation	NULL
of	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
,	NULL
albeit	NULL
leading	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
an	NULL
IRF-1	NULL
GAS-binding	NULL
complex	NULL
,	NULL
is	NULL
not	NULL
accompanied	NULL
by	NULL
IRE-1	NULL
transactivation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
transactivation	NULL
of	NULL
the	NULL
IRF-1	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
is	NULL
short-lived	NULL
,	NULL
although	NULL
binding	NULL
of	NULL
the	NULL
p50/p65	NULL
heterodimer	NULL
to	NULL
the	NULL
IRF-1	NULL
GAS	NULL
can	NULL
be	NULL
detected	NULL
even	NULL
up	NULL
to	NULL
48	NULL
h.	NULL
Thus	NULL
,	NULL
additional	NULL
factors	NULL
are	NULL
likely	NULL
to	NULL
modulate	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
Rel	NULL
family	NULL
members	NULL
at	NULL
this	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
published	NULL
reports	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
,	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
known	NULL
STAT	NULL
proteins	NULL
,	NULL
in	NULL
particular	NULL
of	NULL
Stat3	NULL
and	NULL
Stat6	NULL
,	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
or	NULL
TNF-a	NULL
stimulation	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
constitutive	NULL
complexes	NULL
found	NULL
in	NULL
EBV-transformed	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

While	NULL
these	NULL
studies	NULL
were	NULL
in	NULL
progress	NULL
,	NULL
two	NULL
other	NULL
groups	NULL
also	NULL
reported	NULL
that	NULL
,	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
,	NULL
TNF-a	NULL
can	NULL
activate	NULL
an	NULL
IRF-1	NULL
GAS-binding	NULL
complex	NULL
that	NULL
contains	NULL
Rel	NULL
proteins	NULL
(	NULL
61	NULL
,	NULL
62	NULL
)	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
our	NULL
inability	NULL
to	NULL
detect	NULL
activation	NULL
of	NULL
either	NULL
Stat3	NULL
or	NULL
Stat6	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
is	NULL
at	NULL
present	NULL
unclear	NULL
.	NULL

Potential	NULL
explanations	NULL
include	NULL
the	NULL
fact	NULL
that	NULL
different	NULL
human	NULL
cell	NULL
lines	NULL
as	NULL
well	NULL
as	NULL
different	NULL
culture	NULL
conditions/stimulations	NULL
were	NULL
used	NULL
.	NULL

Because	NULL
we	NULL
can	NULL
detect	NULL
induction	NULL
of	NULL
IRF-1	NULL
,	NULL
€D23	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
Fas	NULL
in	NULL
response	NULL
to	NULL
CD40	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
,	NULL
despite	NULL
the	NULL
intrinsic	NULL
ability	NULL
of	NULL
CD4OR	NULL
to	NULL
trigger	NULL
multiple	NULL
signaling	NULL
pathways	NULL
,	NULL
activation	NULL
of	NULL
selected	NULL
target	NULL
genes	NULL
may	NULL
not	NULL
require	NULL
the	NULL
full	NULL
complement	NULL
of	NULL
signal-transducing	NULL
factors	NULL
.	NULL

The	NULL
interaction	NULL
between	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
and	NULL
STATs	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
diametrically	NULL
opposite	NULL
effects	NULL
in	NULL
different	NULL
experimental	NULL
settings	NULL
.	NULL

While	NULL
synergism	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Stat6	NULL
was	NULL
postulated	NULL
at	NULL
the	NULL
murine	NULL
germline	NULL
epsilon	NULL
promoter	NULL
(	NULL
57	NULL
)	NULL
,	NULL
antagonism	NULL
between	NULL
these	NULL
two	NULL
factors	NULL
was	NULL
found	NULL
at	NULL
the	NULL
E-selectin	NULL
promoter	NULL
(	NULL
63	NULL
)	NULL
.	NULL

Preliminary	NULL
studies	NULL
show	NULL
that	NULL
simultaneous	NULL
targeting	NULL
of	NULL
Rel	NULL
family	NULL
members	NULL
and	NULL
STAT	NULL
's	NULL
to	NULL
the	NULL
IRF-1	NULL
GAS	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
lead	NULL
to	NULL
either	NULL
increased	NULL
transcriptional	NULL
activation	NULL
or	NULL
repression	NULL
of	NULL
the	NULL
IRF-1	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
the	NULL
real	NULL
in	NULL
vivo	NULL
significance	NULL
for	NULL
the	NULL
Rel/STAT	NULL
interaction	NULL
at	NULL
the	NULL
IRF-1	NULL
GAS	NULL
might	NULL
require	NULL
simultaneous	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
multiple	NULL
stimuli	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
,	NULL
IFN-y	NULL
does	NULL
not	NULL
inhibit	NULL
but	NULL
rather	NULL
enhances	NULL
B	NULL
cell	NULL
proliferation	NULL
induced	NULL
by	NULL
CD4O0L	NULL
(	NULL
64	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
involvement	NULL
of	NULL
IRF-1	NULL
in	NULL
growth	NULL
inhibition	NULL
(	NULL
25	NULL
)	NULL
,	NULL
the	NULL
simultaneous	NULL
presence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Stat6	NULL
at	NULL
the	NULL
IRF-1	NULL
GAS	NULL
may	NULL
prevent	NULL
or	NULL
modulate	NULL
the	NULL
ability	NULL
of	NULL
Statl	NULL
to	NULL
induce	NULL
IRF-1	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
precise	NULL
context	NULL
of	NULL
the	NULL
Rel/STAT	NULL
interaction	NULL
rather	NULL
than	NULL
the	NULL
interaction	NULL
per	NULL
se	NULL
will	NULL
dictate	NULL
the	NULL
final	NULL
functional	NULL
outcome	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Rolf	NULL
Freter	NULL
for	NULL
his	NULL
help	NULL
with	NULL
the	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
and	NULL
Dimitris	NULL
Thanos	NULL
for	NULL
the	NULL
recombinant	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
G.	NULL
Siu	NULL
and	NULL
C.	NULL
Schindler	NULL
for	NULL
their	NULL
constant	NULL
support	NULL
and	NULL
helpful	NULL
suggestions	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Grewal	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
R.	NULL
Flavell	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
CD40	NULL
ligand	NULL
:	NULL
at	NULL
the	NULL
center	NULL
of	NULL
the	NULL
immune	NULL
universe	NULL
?	NULL

Immunol	NULL
.	NULL

Res	NULL
.	NULL

16:59	NULL
.	NULL

2.	NULL
van	NULL
Kooten	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1997	NULL
.	NULL

Functions	NULL
of	NULL
CD40	NULL
on	NULL
B	NULL
cells	NULL
,	NULL
dendritic	NULL
cells	NULL
and	NULL
other	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:330	NULL
.	NULL

3	NULL
.	NULL

Laman	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Claassen	NULL
,	NULL
and	NULL
R.	NULL
Noelle	NULL
.	NULL

1996	NULL
.	NULL

Functions	NULL
of	NULL
CD40	NULL
and	NULL
its	NULL
ligand	NULL
,	NULL
gp39	NULL
(	NULL
CD40L	NULL
)	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16:59	NULL
.	NULL

4	NULL
.	NULL

Stout	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
J.	NULL
Suttles	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
many	NULL
roles	NULL
of	NULL
CD40	NULL
in	NULL
cell-mediated	NULL
inflammatory	NULL
responses	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
17:487	NULL
.	NULL

5	NULL
.	NULL

Smith	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Farrah	NULL
,	NULL
and	NULL
R.	NULL
Goodwin	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
TNF	NULL
receptor	NULL
superfamily	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
proteins	NULL
:	NULL
activation	NULL
,	NULL
costimulation	NULL
,	NULL
and	NULL
death	NULL
.	NULL

Cell	NULL
76:959	NULL
.	NULL

6	NULL
.	NULL

Beutler	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
C.	NULL
van	NULL
Huffel	NULL
.	NULL

1994	NULL
.	NULL

Unraveling	NULL
function	NULL
in	NULL
the	NULL
TNF	NULL
ligand	NULL
and	NULL
receptor	NULL
families	NULL
.	NULL

Science	NULL
264:667	NULL
.	NULL

7	NULL
.	NULL

Baker	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
E.	NULL
Reddy	NULL
.	NULL

1996	NULL
.	NULL

Transducers	NULL
of	NULL
life	NULL
and	NULL
death	NULL
:	NULL
TNF	NULL
receptor	NULL
superfamily	NULL
and	NULL
associated	NULL
proteins	NULL
.	NULL

Oncogene	NULL
12:1	NULL
.	NULL

8	NULL
.	NULL

Cheng	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Cleary	NULL
,	NULL
Z.	NULL
Ye	NULL
,	NULL
D.	NULL
Hong	NULL
,	NULL
S.	NULL
Lederman	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Involvement	NULL
of	NULL
CRAFL	NULL
,	NULL
a	NULL
relative	NULL
of	NULL
TRAF	NULL
,	NULL
in	NULL
CD40	NULL
signaling	NULL
.	NULL

Science	NULL
267	NULL
;	NULL
1494	NULL
.	NULL

9	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Sarma	NULL
,	NULL
V.	NULL
Dixit	NULL
,	NULL
and	NULL
D.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

TRAF2-mediated	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
TNF	NULL
receptor	NULL
2	NULL
and	NULL
CD40	NULL
.	NULL

Science	NULL
269:1424	NULL
.	NULL

10	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Birkenbach	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
T.	NULL
vanArsdale	NULL
,	NULL
C.	NULL
Ware	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
LMP1	NULL
engages	NULL
signaling	NULL
proteins	NULL
for	NULL
the	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
receptor	NULL
family	NULL
.	NULL

Cell	NULL
80:389	NULL
.	NULL

11	NULL
.	NULL

Berberich	NULL
,	NULL
L.	NULL
,	NULL
G.	NULL
Shu	NULL
,	NULL
and	NULL
E.	NULL
Clark	NULL
.	NULL

1994	NULL
.	NULL

Cross-linking	NULL
CD40	NULL
on	NULL
B	NULL
cells	NULL
rapidly	NULL
activates	NULL
Nuclear	NULL
Factor-kB	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:4357	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

6003	NULL
Lin	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
Stavnezer	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

by	NULL
CD40	NULL
engagement	NULL
induces	NULL
the	NULL
mouse	NULL
germ	NULL
line	NULL
immunoglobulin	NULL
Cy1	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:4591	NULL
.	NULL

Hess	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Rensing-Ehl	NULL
,	NULL
R.	NULL
Schwabe	NULL
,	NULL
P.	NULL
Bufler	NULL
,	NULL
and	NULL
H.	NULL
Engelmann	NULL
.	NULL

1995	NULL
.	NULL

CD40	NULL
function	NULL
in	NULL
nonhematopoietic	NULL
cells	NULL
.	NULL

Nuclear	NULL
Factor	NULL
kB	NULL
mobilization	NULL
and	NULL
induction	NULL
of	NULL
IL-6	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:4588	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

NF-kB	NULL
:	NULL
ten	NULL
years	NULL
after	NULL
.	NULL

Cell	NULL
87:13	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Anru	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

Snapper	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Zelazowski	NULL
,	NULL
F.	NULL
Rosas	NULL
,	NULL
M.	NULL
Kebry	NULL
,	NULL
M.	NULL
Tian	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
W.	NULL
Sha	NULL
.	NULL

1995	NULL
.	NULL

B	NULL
cells	NULL
from	NULL
p50/NF-KB	NULL
knockout	NULL
mice	NULL
have	NULL
selective	NULL
defects	NULL
in	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
germ-line	NULL
CH	NULL
transcription	NULL
,	NULL
and	NULL
Ig	NULL
class	NULL
switching	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:183	NULL
.	NULL

Snapper	NULL
,	NULL
C.	NULL
,	NULL
F.	NULL
Rosas	NULL
,	NULL
P.	NULL
Zelawzoski	NULL
,	NULL
M.	NULL
Moorman	NULL
,	NULL
M.	NULL
Kehry	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
F.	NULL
Weih	NULL
.	NULL

1996	NULL
.	NULL

B	NULL
cells	NULL
lacking	NULL
RelB	NULL
are	NULL
defective	NULL
in	NULL
proliferative	NULL
responses	NULL
,	NULL
but	NULL
undergo	NULL
normal	NULL
B	NULL
cell	NULL
maturation	NULL
to	NULL
Ig	NULL
secretion	NULL
and	NULL
Ig	NULL
clas	NULL
switching	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1537	NULL
.	NULL

Thile	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
I.	NULL
Kerr	NULL
.	NULL

1995	NULL
.	NULL

Jaks	NULL
and	NULL
Stats	NULL
in	NULL
signaling	NULL
by	NULL
the	NULL
cytokine	NULL
receptor	NULL
superfamily	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

11:69	NULL
.	NULL

O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

1997	NULL
.	NULL

Jaks	NULL
,	NULL
STATs	NULL
,	NULL
cytokine	NULL
signal	NULL
transduction	NULL
,	NULL
and	NULL
immunoregu-lation	NULL
:	NULL
are	NULL
we	NULL
there	NULL
yet	NULL
?	NULL

Immunity	NULL
7:1	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
Darnell	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
responses	NULL
to	NULL
polypeptide	NULL
li-gands	NULL
:	NULL
the	NULL
JAK-STAT	NULL
pathway	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64:621	NULL
.	NULL

Pemnis	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Gupta	NULL
,	NULL
J.	NULL
Yopp	NULL
,	NULL
H.	NULL
Kashleva	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
and	NULL
P.	NULL
Rothman	NULL
.	NULL

1995.	NULL
:	NULL
y	NULL
Chain-associated	NULL
cytokine	NULL
receptors	NULL
signal	NULL
through	NULL
distinct	NULL
transducing	NULL
factors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:14517	NULL
.	NULL

Rothman	NULL
,	NULL
P.	NULL
,	NULL
B.	NULL
Kreider	NULL
,	NULL
D.	NULL
Levy	NULL
,	NULL
U.	NULL
Wegenka	NULL
,	NULL
A.	NULL
Eilers	NULL
,	NULL
T.	NULL
Decker	NULL
,	NULL
F.	NULL
Hom	NULL
,	NULL
H.	NULL
Kashleva	NULL
,	NULL
J.	NULL
Thie	NULL
,	NULL
and	NULL
C.	NULL
Schindler	NULL
.	NULL

1994	NULL
.	NULL

Cytokines	NULL
signal	NULL
through	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
family	NULL
of	NULL
related	NULL
transcription	NULL
factors	NULL
.	NULL

Immunity	NULL
1:457	NULL
.	NULL

Decker	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
Kovarik	NULL
,	NULL
and	NULL
A.	NULL
Meinke	NULL
.	NULL

1997	NULL
.	NULL

GAS	NULL
elements	NULL
:	NULL
a	NULL
few	NULL
nucleotides	NULL
with	NULL
a	NULL
major	NULL
impact	NULL
on	NULL
cytokine-induced	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
.	NULL

17:121	NULL
.	NULL

Vaughan	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
van	NULL
Wijnen	NULL
,	NULL
J.	NULL
Stein	NULL
,	NULL
and	NULL
G.	NULL
Stein	NULL
.	NULL

1997	NULL
.	NULL

Interferon	NULL
regulatory	NULL
factors	NULL
:	NULL
growth	NULL
control	NULL
and	NULL
histone	NULL
gene	NULL
regulation-it	NULL
's	NULL
not	NULL
just	NULL
interferon	NULL
any-more	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Med	NULL
.	NULL

75:348	NULL
.	NULL

Harada	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Kitagawa	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
H.	NULL
Yamamoto	NULL
,	NULL
K.	NULL
Harada	NULL
,	NULL
M.	NULL
Ishihara	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1993	NULL
.	NULL

Anti-oncogenic	NULL
and	NULL
oncogenic	NULL
potentials	NULL
of	NULL
transcriptional	NULL
regulators	NULL
IRF-1	NULL
and	NULL
-2	NULL
.	NULL

Science	NULL
259:971	NULL
.	NULL

Tanaka	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Ishihara	NULL
,	NULL
M.	NULL
Kiagawa	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
T.	NULL
Kimura	NULL
,	NULL
T.	NULL
Matsuyama	NULL
,	NULL
M.	NULL
Lamphier	NULL
,	NULL
S.	NULL
Aizawa	NULL
,	NULL
T.	NULL
Mak	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1994	NULL
.	NULL

Cellular	NULL
commitment	NULL
to	NULL
oncogene-induced	NULL
transformation	NULL
or	NULL
apoptosis	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
transcription	NULL
factor	NULL
IRF-1	NULL
.	NULL

Cell	NULL
77:829	NULL
.	NULL

Tamura	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Ishibara	NULL
,	NULL
M.	NULL
Lamphier	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
L	NULL
Oishi	NULL
,	NULL
S.	NULL
Aizawa	NULL
,	NULL
T.	NULL
Matsuyama	NULL
,	NULL
T.	NULL
Mak	NULL
,	NULL
S.	NULL
Taki	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
IRF-1-dependent	NULL
pathway	NULL
of	NULL
DNA	NULL
damage-induced	NULL
apoptosis	NULL
in	NULL
mitogen-activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
376:596	NULL
.	NULL

Matsuyama	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Kimura	NULL
,	NULL
M.	NULL
Kitagawa	NULL
,	NULL
K.	NULL
Pfeffer	NULL
,	NULL
T.	NULL
Kawakami	NULL
,	NULL
N.	NULL
Watanabe	NULL
,	NULL
T.	NULL
Kundig	NULL
,	NULL
R.	NULL
Amakawa	NULL
,	NULL
K.	NULL
Kishihara	NULL
,	NULL
A.	NULL
Wakeham	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
IRF-1	NULL
or	NULL
IRF-2	NULL
results	NULL
in	NULL
abnormal	NULL
type	NULL
I	NULL
IFN	NULL
gene	NULL
induction	NULL
and	NULL
aberrant	NULL
lymphocyte	NULL
development	NULL
.	NULL

Cell	NULL
75:83	NULL
.	NULL

Kamijo	NULL
,	NULL
R.	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
T.	NULL
Matsuyama	NULL
,	NULL
M.	NULL
Bosland	NULL
,	NULL
J.	NULL
Gerecitano	NULL
,	NULL
D.	NULL
Shapiro	NULL
,	NULL
J	NULL
.	NULL

Le	NULL
,	NULL
S.	NULL
Koh	NULL
,	NULL
T.	NULL
Kimura	NULL
,	NULL
S.	NULL
Green	NULL
,	NULL
T.	NULL
Mak	NULL
,	NULL
and	NULL
J.	NULL
Vilek	NULL
.	NULL

1994	NULL
.	NULL

Requirement	NULL
for	NULL
transcription	NULL
factor	NULL
IRE-1	NULL
in	NULL
NO	NULL
synthase	NULL
induction	NULL
in	NULL
macrophages	NULL
.	NULL

Science	NULL
263:1612	NULL
.	NULL

Duncan	NULL
,	NULL
G.	NULL
,	NULL
H.	NULL
Mittrucker	NULL
,	NULL
D.	NULL
Kagi	NULL
,	NULL
T.	NULL
Matsuyama	NULL
,	NULL
and	NULL
T.	NULL
Mak	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
interferon	NULL
regulatory	NULL
factor-1	NULL
is	NULL
essential	NULL
for	NULL
natural	NULL
killer	NULL
cell	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:2043	NULL
.	NULL

Taki	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Sato	NULL
,	NULL
K.	NULL
Ogasawara	NULL
,	NULL
T.	NULL
Fukuda	NULL
,	NULL
M.	NULL
Sato	NULL
,	NULL
S.	NULL
Hida	NULL
,	NULL
G.	NULL
Suzuki	NULL
,	NULL
M.	NULL
Mitsuyama	NULL
,	NULL
E.	NULL
Shin	NULL
,	NULL
S.	NULL
Kojima	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1997	NULL
.	NULL

Multistage	NULL
regulation	NULL
of	NULL
Th1	NULL
-type	NULL
immune	NULL
responses	NULL
by	NULL
the	NULL
transcription	NULL
factor	NULL
IRF-1	NULL
.	NULL

Immunity	NULL
6:673	NULL
.	NULL

Lohoff	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Ferrick	NULL
,	NULL
H.	NULL
Mittrucker	NULL
,	NULL
G.	NULL
Duncan	NULL
,	NULL
S.	NULL
Bischof	NULL
,	NULL
M.	NULL
Rollinghoff	NULL
,	NULL
and	NULL
T.	NULL
Mak	NULL
.	NULL

1997	NULL
.	NULL

Interferon	NULL
regulatory	NULL
factor-1	NULL
is	NULL
required	NULL
for	NULL
a	NULL
T	NULL
helper	NULL
1	NULL
immune	NULL
response	NULL
in	NULL
vivo	NULL
.	NULL

Immunity	NULL
6:681	NULL
.	NULL

Caldenhoven	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Coffer	NULL
,	NULL
J.	NULL
Yuang	NULL
,	NULL
A.	NULL
V.	NULL
D.	NULL
Stolpe	NULL
,	NULL
F.	NULL
Horn	NULL
,	NULL
W.	NULL
Kruijer	NULL
,	NULL
and	NULL
P.	NULL
Vander	NULL
Saag	NULL
.	NULL

1994	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
human	NULL
intercellular	NULL
adhesion	NULL
mole-cule-1	NULL
promoter	NULL
by	NULL
interleukin-6	NULL
and	NULL
interferon-y	NULL
involves	NULL
binding	NULL
of	NULL
distinct	NULL
factors	NULL
to	NULL
a	NULL
palindromic	NULL
response	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:21146	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
N.	NULL
C.	NULL
Reich	NULL
.	NULL

1993	NULL
.	NULL

Requirement	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
for	NULL
rapid	NULL
activation	NULL
of	NULL
a	NULL
DNA	NULL
binding	NULL
factor	NULL
by	NULL
IL-4	NULL
.	NULL

Science	NULL
262:1265	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
,	NULL
N.	NULL
Halden	NULL
,	NULL
M.	NULL
Lenardo	NULL
,	NULL
and	NULL
W.	NULL
Leonard	NULL
.	NULL

1989	NULL
.	NULL

Functionally	NULL
distinct	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
immunoglobulin	NULL
x	NULL
and	NULL
IL-2	NULL
receptor	NULL
@	NULL
chain	NULL
genes	NULL
.	NULL

Science	NULL
244:466	NULL
.	NULL

Wu	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Lee	NULL
,	NULL
R.	NULL
Bellas	NULL
,	NULL
S.	NULL
Schauer	NULL
,	NULL
M.	NULL
Arsura	NULL
,	NULL
D.	NULL
Katz	NULL
,	NULL
M.	NULL
FitzGerald	NULL
,	NULL
T.	NULL
Rothstein	NULL
,	NULL
D.	NULL
Sherr	NULL
,	NULL
and	NULL
G.	NULL
Sonenshein	NULL
.	NULL

1996	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
induces	NULL
apoptosis	NULL
of	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:4682	NULL
.	NULL

Freter	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Alberta	NULL
,	NULL
G.	NULL
Hwang	NULL
,	NULL
A.	NULL
Wrentmore	NULL
,	NULL
and	NULL
C.	NULL
Stiles	NULL
.	NULL

1996	NULL
.	NULL

Platelet-derived	NULL
growth	NULL
factor	NULL
induction	NULL
of	NULL
the	NULL
immediate-early	NULL
gene	NULL
MCP-1	NULL
is	NULL
mediated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
a	NULL
90-kDa	NULL
phosphoprotein	NULL
coactivator	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:17417	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
Kashleva	NULL
,	NULL
A.	NULL
Pernis	NULL
,	NULL
R.	NULL
Pine	NULL
,	NULL
and	NULL
P.	NULL
Rothman	NULL
.	NULL

1994	NULL
.	NULL

STF-IL4	NULL
:	NULL
a	NULL
novel	NULL
IL-4	NULL
induced	NULL
signal	NULL
transducing	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:1350	NULL
.	NULL

Kohler	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
E.	NULL
Ricber	NULL
.	NULL

1993	NULL
.	NULL

Allergy-associated	NULL
Ie	NULL
and	NULL
Fce	NULL
receptor	NULL
II	NULL
(	NULL
CD23b	NULL
)	NULL
genes	NULL
activated	NULL
via	NULL
binding	NULL
of	NULL
an	NULL
interleukin-4-induced	NULL
transcription	NULL
factor	NULL
to	NULL
a	NULL
novel	NULL
responsive	NULL
clement	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:3066	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
W.	NULL
Henzel	NULL
,	NULL
T.	NULL
Ho	NULL
,	NULL
M.	NULL
Brasseur	NULL
,	NULL
and	NULL
S.	NULL
McKnight	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
interleukin-4-induced	NULL
transcription	NULL
factor	NULL
:	NULL
IL-4	NULL
Stat	NULL
.	NULL

Science	NULL
265:1701	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6004	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

Shuai	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
V.	NULL
Prezioso	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Damell	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
by	NULL
IFN-y	NULL
:	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
91-kD	NULL
DNA	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
258:1808	NULL
.	NULL

Kikutani	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
genetics	NULL
and	NULL
biology	NULL
of	NULL
two	NULL
different	NULL
species	NULL
of	NULL
FceRIL	NULL
Res	NULL
.	NULL

Immunol	NULL
.	NULL

141:249	NULL
.	NULL

Hanissian	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Geba	NULL
.	NULL

1997	NULL
.	NULL

Jak3	NULL
is	NULL
associated	NULL
with	NULL
CD40	NULL
and	NULL
is	NULL
critical	NULL
for	NULL
CD40	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
6:379	NULL
.	NULL

Karras	NULL
,	NULL
J.	NULL
,	NULL
Z.	NULL
Wang	NULL
,	NULL
L.	NULL
Huo	NULL
,	NULL
D.	NULL
Frank	NULL
,	NULL
and	NULL
T.	NULL
Rothstein	NULL
.	NULL

1997	NULL
.	NULL

Induction	NULL
of	NULL
STAT	NULL
protein	NULL
signaling	NULL
through	NULL
the	NULL
CD40	NULL
receptor	NULL
in	NULL
B	NULL
lymphocytes	NULL
:	NULL
distinct	NULL
STAT	NULL
activation	NULL
following	NULL
surface	NULL
Ig	NULL
and	NULL
CD40	NULL
receptor	NULL
engagement	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:4350	NULL
.	NULL

Kim	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
transcriptional	NULL
synergy	NULL
of	NULL
an	NULL
in	NULL
vitro	NULL
assembled	NULL
interferon-B	NULL
enhanceosome	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
1:119	NULL
.	NULL

Yamada	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Ogawa	NULL
,	NULL
K.	NULL
Akagi	NULL
,	NULL
H.	NULL
Miyamoto	NULL
,	NULL
N.	NULL
Nakano	NULL
,	NULL
S.	NULL
Itoh	NULL
,	NULL
J.	NULL
Miyazaki	NULL
,	NULL
S.	NULL
Nishikawa	NULL
,	NULL
K.	NULL
Yamamura	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1991	NULL
.	NULL

Specific	NULL
depletion	NULL
of	NULL
the	NULL
B-cell	NULL
population	NULL
induced	NULL
by	NULL
aberrant	NULL
expression	NULL
of	NULL
human	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:532	NULL
.	NULL

Eisenbeis	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
Singh	NULL
,	NULL
and	NULL
U.	NULL
Storb	NULL
.	NULL

1995	NULL
.	NULL

Pip	NULL
,	NULL
a	NULL
novel	NULL
IRF	NULL
family	NULL
member	NULL
,	NULL
is	NULL
a	NULL
lymphoid-specific	NULL
,	NULL
PU.1-dependent	NULL
transcriptional	NULL
activator	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1377	NULL
.	NULL

Tida	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Rao	NULL
,	NULL
M.	NULL
Butler	NULL
,	NULL
P.	NULL
Corradini	NULL
,	NULL
M.	NULL
Boccadoro	NULL
,	NULL
B.	NULL
Klein	NULL
,	NULL
R.	NULL
Chaganti	NULL
,	NULL
and	NULL
R.	NULL
Dalla-Favera	NULL
.	NULL

1997	NULL
.	NULL

Deregulation	NULL
of	NULL
MUM1/IRF4	NULL
by	NULL
chromosomal	NULL
translocation	NULL
in	NULL
multiple	NULL
myeloma	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

17:226	NULL
.	NULL

Matsuyama	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Grossman	NULL
,	NULL
H.	NULL
Mittrucker	NULL
,	NULL
D.	NULL
Siderovski	NULL
,	NULL
F.	NULL
Kiefer	NULL
,	NULL
T.	NULL
Kawakami	NULL
,	NULL
C.	NULL
Richardson	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
S.	NULL
Yoshinaga	NULL
,	NULL
and	NULL
T.	NULL
Mak	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
LSIRF	NULL
,	NULL
a	NULL
lymphoid-specific	NULL
member	NULL
of	NULL
the	NULL
interferon	NULL
regulatory	NULL
factor	NULL
family	NULL
that	NULL
binds	NULL
the	NULL
interferon-stimulated	NULL
response	NULL
element	NULL
(	NULL
ISRE	NULL
)	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23:2127	NULL
.	NULL

Yamagata	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Nishida	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
R.	NULL
Sakai	NULL
,	NULL
K.	NULL
Mitani	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
Y.	NULL
Yazaki	NULL
,	NULL
and	NULL
H.	NULL
Hirai	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
novel	NULL
interferon	NULL
regulatory	NULL
factor	NULL
family	NULL
transcription	NULL
factor	NULL
,	NULL
ICSAT/Pip/LSIRF	NULL
,	NULL
that	NULL
negatively	NULL
regulates	NULL
the	NULL
activity	NULL
of	NULL
in-terferon-regulated	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1283	NULL
.	NULL

Mittrucker	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Matsuyama	NULL
,	NULL
A.	NULL
Grossman	NULL
,	NULL
T.	NULL
Kundig	NULL
,	NULL
J.	NULL
Potter	NULL
,	NULL
A.	NULL
Shahinian	NULL
,	NULL
A.	NULL
Wakeham	NULL
,	NULL
B.	NULL
Patterson	NULL
,	NULL
P.	NULL
Ohashi	NULL
,	NULL
and	NULL
T.	NULL
Mak	NULL
.	NULL

1997	NULL
.	NULL

Requirement	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
LSIRF/IRP4	NULL
for	NULL
mature	NULL
B	NULL
and	NULL
T	NULL
lymphocyte	NULL
function	NULL
.	NULL

Science	NULL
275:540	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

CONVERGENCE	NULL
OF	NULL
SIGNALS	NULL
BY	NULL
TNF-	NULL
AND	NULL
CYTOKINE-RECEPTOR	NULL
FAMILIES	NULL
Aggarwal	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
K.	NULL
Natarajan	NULL
.	NULL

1996	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factors	NULL
:	NULL
developments	NULL
during	NULL
the	NULL
last	NULL
decade	NULL
.	NULL

Eur	NULL
.	NULL

Cytokine	NULL
Netw	NULL
.	NULL

7:93	NULL
.	NULL

Licbowitz	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
Virus	NULL
.	NULL

In	NULL
The	NULL
Human	NULL
Herpesvi-ruses	NULL
.	NULL

B.	NULL
Roizman	NULL
,	NULL
R.	NULL
J.	NULL
Whitley	NULL
,	NULL
and	NULL
C.	NULL
Lopez	NULL
,	NULL
eds	NULL
.	NULL

pp	NULL
.	NULL

107-172	NULL
.	NULL

Schaefer	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Paulson	NULL
,	NULL
J.	NULL
Strominger	NULL
,	NULL
and	NULL
S.	NULL
Speck	NULL
.	NULL

1997	NULL
.	NULL

Constitutive	NULL
activation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
nuclear	NULL
antigen	NULL
1	NULL
gene	NULL
transcription	NULL
by	NULL
IRF1	NULL
and	NULL
IRF2	NULL
during	NULL
restricted	NULL
EBV	NULL
latency	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:873	NULL
.	NULL

Zhang	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
J.	NULL
Pagano	NULL
.	NULL

1997	NULL
.	NULL

IRF-7	NULL
,	NULL
a	NULL
new	NULL
interferon	NULL
regulatory	NULL
factor	NULL
associated	NULL
with	NULL
Epstein-Barr	NULL
virus	NULL
latency	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:5748	NULL
.	NULL

Nonkwelo	NULL
,	NULL
C.	NULL
,	NULL
I.	NULL
Ruf	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Sample	NULL
.	NULL

1997	NULL
.	NULL

Interferon-independent	NULL
and-induced	NULL
regulation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
EBNA-1	NULL
gene	NULL
transcription	NULL
in	NULL
Burkitt	NULL
lym-phoma	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:6887	NULL
.	NULL

Iciek	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Delphin	NULL
,	NULL
and	NULL
J.	NULL
Stavnezer	NULL
.	NULL

1997	NULL
.	NULL

CD40	NULL
cross-linking	NULL
induces	NULL
Ige	NULL
germline	NULL
transcripts	NULL
in	NULL
B	NULL
cells	NULL
via	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:4769	NULL
.	NULL

Liou	NULL
,	NULL
H.	NULL
,	NULL
W.	NULL
Sha	NULL
,	NULL
M.	NULL
Scott	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1994	NULL
.	NULL

Sequential	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
proteins	NULL
during	NULL
B-cell	NULL
terminal	NULL
differentiation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:5349	NULL
.	NULL

Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Schmitt	NULL
,	NULL
and	NULL
I.	NULL
Verma	NULL
.	NULL

1994	NULL
.	NULL

Qualitative	NULL
changes	NULL
in	NULL
the	NULL
subunit	NULL
composition	NULL
of	NULL
xB-binding	NULL
complexes	NULL
during	NULL
murine	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:5056	NULL
.	NULL

Grumont	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
S.	NULL
Gerondakis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
subunit	NULL
composition	NULL
of	NULL
NF-B	NULL
complexes	NULL
changes	NULL
during	NULL
B-cell	NULL
development	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

5:1321	NULL
.	NULL

Ohmori	NULL
,	NULL
Y.	NULL
,	NULL
R.	NULL
Screiber	NULL
,	NULL
and	NULL
T.	NULL
Hamilton	NULL
.	NULL

1997	NULL
.	NULL

Synergy	NULL
between	NULL
interferon-y	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
in	NULL
transcriptional	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
cooperation	NULL
between	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
1	NULL
and	NULL
nuclear	NULL
factor	NULL
xB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:14899	NULL
.	NULL

Pine	NULL
,	NULL
R.	NULL
1997	NULL
.	NULL

Convergence	NULL
of	NULL
TNFa	NULL
and	NULL
IFNy	NULL
signaling	NULL
pathways	NULL
through	NULL
synergistic	NULL
induction	NULL
of	NULL
IRF-1/ISGF2	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
composite	NULL
GAS/xB	NULL
promoter	NULL
element	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

25:4346	NULL
.	NULL

Bennett	NULL
,	NULL
B.	NULL
,	NULL
R.	NULL
Cruz	NULL
,	NULL
R.	NULL
Lacson	NULL
,	NULL
and	NULL
A.	NULL
Manning	NULL
.	NULL

1997	NULL
.	NULL

Interleukin-4	NULL
suppression	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
o-stimulated	NULL
E-selectin	NULL
gene	NULL
transcription	NULL
is	NULL
mediated	NULL
by	NULL
STAT6	NULL
antagonism	NULL
of	NULL
NF-kB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:10212	NULL
.	NULL

Armitage	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
Macduff	NULL
,	NULL
M.	NULL
Spriggs	NULL
,	NULL
and	NULL
W.	NULL
Fanslow	NULL
.	NULL

1993	NULL
.	NULL

Human	NULL
B	NULL
cell	NULL
proliferation	NULL
and	NULL
Ig	NULL
secretion	NULL
induced	NULL
by	NULL
recombinant	NULL
CD40	NULL
Ligand	NULL
are	NULL
modulated	NULL
by	NULL
soluble	NULL
cytokines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:3671	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

